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1 Refer to CHBRP’s full report for full citations and references. 
2 In California, qualified health plans (QHPs) are 
nongrandfathered small-group and individual market DMHC-
regulated plans and CDI-regulated policies sold in Covered 
California, the state’s online marketplace. 
CONTEXT 
Research in the 1990s found that early identification and 
treatment of hearing loss in children prevented delays in 
speech, language, and cognitive development, which led 
to the implementation of universal newborn hearing 
screening programs in the United States.1 
The California Newborn Hearing Screening Program 
requires California hospitals to screen newborns for 
hearing loss before discharge. The state also screens for 
hearing loss among school-aged children in public 
schools. As for hearing screening more generally, this 
service is covered as a preventive service among qualified 
health plans2 as an essential health benefit.  
California Children’s Services  
California Children’s Services (CCS) is a state program 
that provides coverage for children under age 21 years 
with certain eligible medical conditions, including 
qualifying hearing loss. Children may qualify for CCS by 
meeting certain age, residence, medical, and financial 
requirements. All children in Medi-Cal under age 21 years 
(both fee-for-service and Medi-Cal Managed Care) receive 
medically necessary hearing aid services through this 
program.3 Other children may be eligible, as described in 
the Policy Context section.  
Types of Hearing Aids and Devices 
Considered 
Based on the definition in the bill language, this analysis 
examines the use of conventional hearing aids and also 
the non-surgically implanted, wearable bone conduction 
hearing aids (BCHA) (including, but not limited to, the 
brand name “BAHA Softband”). Conventional hearing aids 
capture vibration through microphone(s) and play the 
sound back in the ear canal. Conversely, BCHA captures 
3 All Medi-Cal recipients younger than 21 years of age who 
require hearing services must be referred to California Children’s 
Services (CCS) for hearing services. 
AT A GLANCE 
Assembly Bill (AB) 598 would require coverage for hearing aids 
when medically necessary for enrollees under 18 years of age in 
Department of Managed Health Care (DMHC)-regulated plans and 
California Department of Insurance (CDI)-regulated policies.  
1. Background on pediatric hearing loss. Children 
may experience hearing loss in one or both ears. 
Nationwide, hearing loss in one ear (unilateral) occurs 
in about 2.7% of adolescents aged 12 to 19 years, 
whereas hearing loss in both ears (bilateral) is less 
common at 0.8% of adolescents (Shargorodsky et al., 
2010). This prevalence accounts for congenital 
hearing loss (present at birth) and acquired. 
2. Enrollees covered. CHBRP estimates that all state-
regulated coverage (24.49 million Californians) would 
be subject to AB 598, with 7.258 million age 0–17 
years. 
3. Impact on expenditures. CHBRP estimates that AB 
598 would increase total net annual expenditures by 
$2,684,000 in the first year postmandate. 
a. Shifting costs. Although CHBRP does not 
anticipate a major increase in utilization, there 
would be a shift in costs from enrollee out-of-
pocket expenditures to costs paid by health plans 
and policies for children’s hearing aids and 
services. 
4. Essential health benefits (EHBs). Coverage required 
by AB 598 could be interpreted to exceed EHBs as 
this benefit is not included in the state’s benchmark 
plan. CHBRP estimates the total state-responsibility in 
the first year could be $2.1 million to $3.07 million. 
5. Medical effectiveness. It is generally accepted that 
the use of hearing aids improves the hearing of 
children with hearing loss. A preponderance of 
evidence suggests that hearing aids are effective in 
improving speech and language outcomes among 
children with hearing loss. Early and consistent use of 
hearing aids is associated with better speech and 
language outcomes. 
6. Benefit coverage. Currently, CHBRP estimates that 
in privately funded plans and policies, about 11% of 
enrollees aged 0 to 17 have coverage for hearing aids 
and services. In publicly funded plans, CHBRP 
estimates that 100% of enrollees aged 0 to 17 have 
coverage for hearing aids and services. 
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vibrations via microphone and transmits to the bones of 
the skull and thus to the inner ear. For the wearable 
BCHA, the device is worn on a removable headband, 
rather than surgically implanted. This analysis did not 
include cochlear implants.4 
BILL SUMMARY  
AB 598 would require DMHC-regulated plans and CDI-
regulated policies issued, amended, or renewed on or 
after January 1, 2020, to include coverage for hearing aids 
for enrollees under 18 years when medically necessary. 
Coverage includes an initial assessment, new hearing 
aids at least every 5 years, new ear molds, new hearing 
aids if alterations to existing hearing aids cannot meet the 
needs of the child, a new hearing aid if the existing one is 
no longer working, and fittings, adjustments, auditory 
training, and maintenance of the hearing aids. 
Hearing aids are defined in the bill as “an electronic 
device usually worn in or behind the ear of a deaf and 
hard of hearing person for the purpose of amplifying 
sound.” The bill language does not specify a dollar 
amount coverage cap. 
The bill would add a new section to the Health and Safety 
Code (1367.72) and to the Insurance Code (10123.72). 
AB 598 excludes Medicare supplement, dental-only, and 
vision-only plans from the Health and Safety code 
provisions. The bill excludes accident-only, specified 
disease, hospital indemnity, Medicare supplement, dental-
only, and vision-only policies from the Insurance Code 
provision.  
IMPACTS 
Benefit Coverage, Utilization, and Cost  
Benefit Coverage 
CHBRP estimates that currently, approximately 49.1% of 
enrollees aged 0 to 17 years in California with health 
insurance have coverage that is compliant with AB 598. 
This estimate includes children in both privately funded  
                                                     
4 Refer to CHBRP’s full report for full citations and references. 
Figure A. Health Insurance in CA and AB 598 
 
Source: California Health Benefits Review Program, 2019. 
Notes: *Medicare beneficiaries, enrollees in self-insured products, etc. 
and publicly funded health insurance products regulated 
by DMHC or CDI. CHBRP estimates that approximately: 
• 11% of enrollees aged 0 to 17 in privately funded 
products have coverage for hearing aids and 
services; and  
• 100% of enrollees aged 0 to 17 in publicly funded 
plans have coverage for hearing aids and 
services.   
Postmandate, 100% of enrollees aged 0 to 17 with health 
insurance would have mandate-compliant coverage of 
hearing aids. 
Utilization 
Given the necessity of hearing aids for children who need 
them, parents and guardians may find a way to obtain 
hearing aids even without insurance coverage. Some 
evidence suggests that hearing aids are largely price 
inelastic; in other words, the purchase and use of hearing 
aids may be largely unaffected by price.  
• CHBRP estimates that the removal of a cost 
barrier when coverage is introduced for hearing 
aids would thus result in a modest increase in 
utilization of 2.4% among enrollees who do not 
have coverage for hearing aids and services 
postmandate.  
• CHBRP estimates no change in utilization among 
the population with coverage postmandate. 
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• The combined rate of utilization for the total 
population of enrollees aged 0 to 17 postmandate 
is estimated at 1.2% (see full Benefit Coverage, 
Utilization, and Cost Impacts section for 
description). 
CHBRP estimates that an additional 195 children needing 
hearing aids or services would be newly covered under 
AB 598 in the first year. For some, this permits first-time 
use of hearing aids, and for all newly covered hearing aid 
users, it permits more repairs, replacements, testing, and 
recasted ear molds, which improve the effectiveness of 
the hearing aids. All of these newly covered children 
would be in privately funded health insurance plans or 
policies since Medi-Cal and CalPERS currently cover 
hearing aids and services.  
Postmandate, CHBRP estimates there would be no 
change in the average per enrollee cost of hearing aids 
and services. CHBRP estimates hearing aids and services 
cost on average $1,825 per enrollee, which includes 
children who may not have purchased a new hearing aid 
in the given year, but may use related hearing aid services 
in that year.  
Expenditures 
CHBRP estimates that AB 598 would increase total net 
annual expenditures by $2,685,000 in the first year 
postmandate. Notably, although CHBRP does not 
anticipate a major increase in utilization, there would be a 
shift in costs from enrollee out-of-pocket expenditures to 
costs paid by health plans and policies.  
Prior to the mandate, enrollees without coverage for AB 
598 incurred an estimated $13,586,000 in out-of-pocket 
expenses. Postmandate, that $13,586,000 in out-of-
pocket expenses would be shifted to health plans and 
insurers. However, enrollees would incur $2,462,000 in 
copayments for the newly covered benefits (enrollee out-
of-pocket expenses for covered benefits). See Figure 2.  
 
Figure B. Expenditure Impacts of AB 598 
Net change: $2.684 million 
 
Source: California Health Benefits Review Program, 2019.  
 
Medi-Cal 
Because children in Medi-Cal (both fee-for-service and 
Medi-Cal Managed Care) receive medically necessary 
hearing aid services through CCS, there would be no 
measurable impact on Medi-Cal as a result of AB 598 
CalPERS 
CHBRP estimates no measureable impact on enrollees in 
state-regulated CalPERS plans.  
Number of Uninsured in California 
AB 598 would have no measureable impact projected on 
the number of uninsured in California.  
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Medical Effectiveness 
It is generally accepted that the use of hearing aids 
improves the hearing of children with hearing loss. As a 
result, there have been few recent studies on the impact 
of hearing aids on hearing in children.  
CHBRP concludes that there is a preponderance of 
evidence from studies with moderately strong research 
designs that: 
• Hearing aids are effective in improving speech 
outcomes in children. In particular, evidence suggests 
that earlier age of fitting with hearing aid is associated 
with greater gains in speech outcomes. 
• Hearing aids are effective in improving language 
development outcomes in children. In particular, risk 
for language delays in children with hearing loss may 
be mitigated from an early age of fitting and consistent 
use of hearing aids. 
Conversely, there is insufficient evidence that hearing aids 
are effective in improving nonverbal outcomes (e.g., motor 
behavior) in children. There is conflicting evidence that 
hearing aids are effective in improving personal and social 
development outcomes in children. 
Public Health 
Hearing loss may be congenital (present at birth) or 
acquired later during childhood. Children may experience 
hearing loss in one or both ears, and may require either 
one or two hearing aids. Nationwide, hearing loss in one 
ear (unilateral) occurs in about 2.7% of adolescents aged 
12 to 19, whereas hearing loss in both ears (bilateral) is 
less common at 0.8% of adolescents (Shargorodsky et al., 
2010). This overall prevalence rate of 3.5% among 
adolescents includes both congenital and acquired 
hearing loss.  
CHBRP projects that AB 598 would increase the first-time 
use of hearing aids and services by 195 children (all in the 
privately funded insurance market) in the first year 
postmandate; thus, assuming new coverage is similar to 
premandate cost sharing, hearing and speech and 
language skills would be expected to improve for this 
subset of newly covered children with hearing loss who 
were unable to afford hearing aids premandate. 
No literature was found that discussed the receipt of 
hearing aids and its effect on ameliorating existing 
disparities in hearing loss by gender, income, and 
maternal education (as described in the Medical 
Effectiveness section). CHBRP estimates that AB 598 
would reduce the net financial burden of out-of-pocket 
expenses by approximately $11.124 million for the families 
of children who use hearing aids and services in the first 
year, postmandate. 
Long-Term Impacts 
CHBRP estimates AB 598 would have minimal impacts on 
utilization. Premium expenditures by payer increase with 
AB 598. However, as technology changes, it is possible 
that unit costs of these devices will change. In the 
absence of data on likely changes to unit cost of hearing 
aids, the long-term impact is not quantifiable.  
Regarding public health impacts, It is unknown the degree 
to which the passage of AB 598 would improve the future 
educational attainment and employment status of children 
who obtain hearing aids through the new coverage. 
However, it stands to reason that those who use hearing 
aids at a young age and maintain their communication 
skills into adulthood would experience improved outcomes 
as compared with not using hearing aids. 
Essential Health Benefits and the 
Affordable Care Act 
The state’s benchmark plan, which determines which 
services are included as a part of California’s essential 
health benefits (EHBs), does not include coverage for 
hearing aids.  
 
Coverage for children’s hearing aids and associated 
services (e.g., replacement, repair) mandated by AB 598 
appears to exceed EHBs, and therefore would appear to  
trigger the ACA requirement that the state defray the cost 
of additional benefit coverage for enrollees in qualified 
health plans (QHPs) in Covered California. A state that 
requires QHPs to offer benefits in excess of the EHBs 
could be required to make payments to defray the cost of 
those additionally mandated benefits, either by paying the 
purchaser directly or by paying the QHP. 
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CHBRP estimates that the state could be required to 
defray the following (net of baseline coverage offsets) 
amounts due to AB 598: 
• $0.12 PMPM for each QHP enrollee in a small-
group DMHC-regulated plan; 
• $0.08 PMPM for each QHP enrollee in an 
individual market DMHC-regulated plan; 
• $0.07 PMPM for each QHP enrollee in a small-
group CDI-regulated policy; and 
• $0.08 PMPM for each QHP enrollee in an 
individual market CDI-regulated policy. 
 
CHBRP estimates that this could translate to a state-
responsibility of $2,102,000 to $3,067,000 total. These 
estimates are broken down by regulated market in the 
Benefit Coverage, Utilization, and Cost Impacts section of 
the full report. 
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ABOUT CHBRP 
The California Health Benefits Review Program (CHBRP) was established in 2002. As per its authorizing 
statute, CHBRP provides the California Legislature with independent analysis of the medical, financial, 
and public health impacts of proposed health insurance benefit-related legislation. The state funds 
CHBRP through an annual assessment on health plans and insurers in California.  
An analytic staff based at the University of California, Berkeley, supports a task force of faculty and 
research staff from multiple University of California campuses to complete each CHBRP analysis. A 
strict conflict-of-interest policy ensures that the analyses are undertaken without bias. A certified, 
independent actuary helps to estimate the financial impact. Content experts with comprehensive 
subject-matter expertise are consulted to provide essential background and input on the analytic 
approach for each report.  
More detailed information on CHBRP’s analysis methodology, authorizing statute, as well as all 
CHBRP reports and other publications are available at www.chbrp.org. 
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Table 1. AB 598 Impacts on Benefit Coverage, Utilization, and Cost, 2020 
  Baseline Postmandate Increase/ 
Decrease 
Percentage 
Change 
Benefit coverage 
 Total enrollees with health insurance 
subject to state-level benefit mandates 
(a) 
24,490,000 24,490,000 0 0% 
 Total enrollees aged 0–17 years with 
health insurance subject to AB 598 
7,258,000 7,258,000 0 0% 
 Percentage of enrollees aged 0–17 years 
with coverage for hearing aids and 
services (i.e., health insurance compliant 
with AB 598) 
49.1% 100.0% 50.9% 104% 
 Number of enrollees aged 0–17 years 
with coverage for hearing aids and 
services (i.e., health insurance compliant 
with AB 598)  
3,561,000 7,258,000 3,697,000 104% 
Utilization and unit cost 
 Total enrollees aged 0–17 years subject 
to AB598 using hearing aids and/or 
related services 
16,327  16,522  195 1.2% 
Hearing aid and services for enrollees aged 0–17 with hearing aid coverage (number of services) 
 Hearing aids 5,900  11,882  5,981 101% 
 Hearing aid maintenance & 
repair 
1,494  3,009  1,515 101% 
 Ear mold 5,090  10,250  5,160 101% 
 Diagnostic test, hearing aid 
checks, fittings and 
adjustments (c) 
7,040  14,176  7,137 101% 
Hearing aid and services for enrollees aged 0–17 with no hearing aid coverage (number of services) 
 Hearing aids 5,841  0 -5,841 -100% 
 Hearing aid maintenance & 
repair 
1,479  0 -1,479 -100% 
 Ear mold 5,039  0 -5,039 -100% 
 Diagnostic test, hearing aid 
checks, fittings and 
adjustments (c) 
6,969  0 -6,969 -100% 
 Hearing aid and/or services average 
cost per user (d) 
$1,825 $1,825 $0 0% 
Expenditures 
Premiums by payer 
 Private employers for 
group insurance 
$86,438,375,000 $86,448,713,000 $10,338,000 0.0120% 
 CalPERS HMO employer 
expenditures (c) 
$3,098,551,000 $3,098,551,000 $0 0.0000% 
 Medi-Cal Managed Care 
Plan expenditures 
$28,492,273,000 $28,492,273,000 $0 0.0000% 
 Enrollees with individually 
purchased insurance 
$12,045,324,000 $12,046,841,000 $1,517,000 0.0126% 
 Enrollees with group 
insurance, CalPERS 
HMOs, Covered California, 
and Medi-Cal Managed 
Care (c) 
$2,486,222,000 $2,486,591,000 $369,000 0.0148% 
Enrollee expenses 
 For covered benefits 
(deductibles, copayments, 
etc.) 
$14,750,880,000 $14,753,342,000 $2,462,000 0.0167% 
 For noncovered benefits 
(d) 
$13,586,000 $0 -$13,586,000 -100.00% 
Total expenditures $159,315,383,000 $159,318,067,000 $2,684,000 0.0017% 
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Source: California Health Benefits Review Program, 2019. 
Notes: (a) Enrollees in plans and policies regulated by DMHC or CDI aged 0 to 64 years as well as enrollees 65 years or older in 
employer-sponsored health insurance. This group includes commercial enrollees (including those associated with Covered 
California or CalPERS) and Medi-Cal beneficiaries enrolled in DMHC-regulated plans.5  
(c) Enrollee premium expenditures include contributions by employees to employer-sponsored health insurance, health insurance 
purchased through Covered California, and contributions to Medi-Cal Managed Care. 
(d) Includes only expenses paid directly by enrollees (or other sources) to providers for services related to the mandated benefit that 
are not currently covered by insurance. This only includes those expenses that will be newly covered postmandate. Other 
components of expenditures in this table include all health care services covered by insurance. 
Key: CalPERS = California Public Employees’ Retirement System; CDI = California Department of Insurance; DMHC = Department 
of Managed Health Care; HMO = Health Maintenance Organizations. 
 
 
 
                                                     
5 For more detail, see 2020 Estimates of Sources of Health Insurance in California, available at  
http://chbrp.com/analysis_methodology/cost_impact_analysis.php.   
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POLICY CONTEXT 
The California Assembly Committee on Health has requested that the California Health Benefits Review 
Program (CHBRP)6 conduct an updated impact analysis (drawn from its prior 2017 evidence-based 
updated assessment of the medical, financial, and public health impacts of Assembly Bill 1601) of 
Assembly Bill 598, Hearing Aids for Minors. 
Bill-Specific Analysis of AB 598, Hearing Aids for Minors 
The California Assembly Health Committee has requested that the California Health Benefits Review 
Program (CHBRP) conduct an evidence-based assessment of the medical, financial, and public health 
impacts of California Assembly Bill (AB) 598. 
If enacted, AB 598, would affect the health insurance of approximately 24.490 million enrollees (61.6% of 
all Californians); of these, 7,258,000 are enrollees aged 0 to 17 years old. This represents 100% of the 
24.490 million Californians who will have health insurance regulated by the state in 2020 that may be 
subject to any state health benefit mandate law — health insurance regulated by the California 
Department of Managed Health Care (DMHC) or the California Department of Insurance (CDI). The bill 
excludes Medicare supplement, dental-only, and vision-only plans from the Health and Safety code 
provisions and excludes accident-only, specified disease, hospital indemnity, Medicare supplement, 
dental-only, and vision-only policies from the Insurance Code provisions. 
Because analysis of a similar introduced bill was completed in 2016 for AB 2004 (Bloom) Hearing Aids, 
CHBRP has drawn from the AB 2004 report to inform this analysis. CHBRP expects that many of the 
impacts projected in its analysis of AB 2004 to be similar, as the language and intent of both bills are very 
similar. For the purpose of CHBRP’s cost analyses, the bill language is similar enough to not require a 
new CHBRP cost analysis approach. To project the impact of AB 598, the updated cost analysis uses 
more recent claims data and an updated model reflecting the estimated 2020 population in state-
regulated plans and policies. CHBRP also provides an updated public health analysis. CHBRP did not 
expect any major changes to the medical effectiveness literature and has included the AB 2004 medical 
effectiveness analysis for reference.  
Bill Language 
AB 598 would require DMHC-regulated health plans and CDI-regulated policies to provide coverage of 
hearing aids for children aged 0 to 17 years, as well as publicly funded plans (including CalPERS and 
Medi-Cal Managed Care Plans that are subject to the Knox-Keene Health Care Service Plan Act). The full 
text of AB 598 can be found in Appendix A. 
Interaction With Existing Requirements 
Health benefit mandates may interact and align with the following state and federal mandates or 
provisions. 
                                                     
6 CHBRP’s authorizing statute is available at http://chbrp.org/faqs.php. 
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California Policy Landscape 
California law and regulations 
California law requires screening for hearing loss among children, first at birth in the Newborn Hearing 
Screening Program and subsequently at school age (for students in the public school system) (NCSL, 
2011).7,8,9 For more information about these programs, please see the Background on Hearing Aids: 
Minors section.   
There is no existing law mandating any kind of coverage for hearing aids for private insurance. However, 
for children age 21 years and under in Medi-Cal and children who meet certain qualifications10 including a 
qualifying hearing loss, hearing aids are covered through California Children’s Services (CCS). CCS is a 
state program that provides coverage for children under age 21 with certain eligible medical conditions, 
including hearing loss. Children may also qualify for CCS by meeting certain age, residence, medical, and 
financial requirements.11,12   
The eligibility criteria are:  
Age: Child must be under 21; 
Residence: Child must be California resident; 
Medical condition: Child has a medical condition that is covered by CCS, as determined by the 
California Code of Regulations;13 
Financial and other: Child and family meets one of the following criteria:  
Family income of $40,000 or less; 
Out-of-pocket medical expenses expected to be more than 20% of family's adjusted gross 
income; 
A need for an evaluation to find out whether there is a health problem covered by CCS; 
Child was adopted with a known health problem that is covered by CCS; 
Child has a need for the Medical Therapy Program (a state program that provides services for 
children who have handicapping conditions, generally due to neurological or musculoskeletal 
disorders); or 
Medi-Cal, with full benefits. 
For children who meet the stated criteria, CCS covers qualifying hearing loss as defined by the California 
Code of Regulations.14  
                                                     
7 Cal. Health and Safety Code § 123975. 
8 Cal. Health and Safety Code § 124115 et seq. 
9 California Code of Regulations, Title 17, Section 2952 (c)(1). 
10 Some privately insured children are eligible based on income guidelines. 
11 Medi-Cal Provider Manual. Part 2 – Audiology and Hearing Aids (AUD), California Children’s Services (CCS) 
Program. 
12 http://www.dhcs.ca.gov/services/ccs/Pages/qualify.aspx. 
13 California Code of Regulations, Title 22, Article 1, Sections 41811 through 41876. 
14 22 CCR § 41518 § 41518. Diseases of the Ear and Mastoid Process. 
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Medi-Cal recipients under age 21 must be referred to CCS for hearing loss services, including hearing 
aids,15 both for fee-for-service and managed care. For Medi-Cal beneficiaries in county organized health 
system (COHS) plans, the COHS plans, rather than CCS, provide hearing services.16,17,18  
Having private insurance does not preclude a child from receiving services through CCS. If they meet one 
or more of the previously mentioned requirements, children with private insurance may receive coverage 
through CCS for certain conditions (e.g., hearing loss) that their insurance does not cover or for services 
that meet the out-of-pocket medical expense eligibility above.19 
Similar requirements in other states 
Colorado, Delaware, Georgia, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, 
Missouri, New Jersey, New Mexico, North Carolina, Oklahoma, Oregon, Tennessee, and Texas require 
that health benefits plans in their state pay for hearing aids for children. Arkansas, Connecticut, Illinois, 
New Hampshire, and Rhode Island require coverage for both children and adults. Wisconsin requires 
coverage for both hearing aids and cochlear implants for children. Requirements vary state by state for 
ages covered, amount of coverage, benefit period, and provider qualifications. 
Of the 20 states that mandate coverage of hearing aids for children, California’s proposed legislation is 
most similar to Colorado’s law, which requires plans to cover hearing aids for children younger than 18 
years when medically necessary. Under Colorado’s law, effective January 1, 2009, coverage includes 
new hearing aid(s) every 5 years, a new hearing aid when alterations to the existing hearing aid(s) cannot 
meet the needs of the child, and services and supplies such as the initial assessment, fitting, 
adjustments, and auditory training. Source: American Speech-Language-Hearing Association: 
https://www.asha.org/advocacy/state/issues/ha_reimbursement/. 
Federal Policy Landscape 
Affordable Care Act 
A number of Affordable Care Act (ACA) provisions have the potential to or do interact with state benefit 
mandates. Below is an analysis of how AB 598 may interact with requirements of the ACA as presently 
exists in federal law, including the requirement for certain health insurance to cover essential health 
benefits (EHBs).20 
Any changes at the federal level may impact the analysis or implementation of this bill, were it to pass into 
law. However, CHBRP analyzes bills in the current environment given current law and regulations.  
Essential Health Benefits 
State health insurance marketplaces, such as Covered California, are responsible for certifying and 
selling qualified health plans (QHPs) in the small-group and individual markets. QHPs are required to 
meet a minimum standard of benefits as defined by the ACA as essential health benefits (EHBs). In 
                                                     
15 Medi-Cal Provider Manual. Part 2 – Audiology and Hearing Aids (AUD). 
16 Email correspondence with DHCS, March 24, 2016. 
17 These COHS counties are Marin, Napa, San Mateo, Solano, Santa Barbara, and Yolo. 
18 CHBRP analyses exclude COHS plans. 
19 Personal communication with Margaret Winter, March 15, 2016. 
20 The ACA requires nongrandfathered small-group and individual market health insurance — including but not limited 
to QHPs sold in Covered California — to cover 10 specified categories of EHBs. Resources on EHBs and other ACA 
impacts are available on the CHBRP website: http://www.chbrp.org/other_publications/index.php. 
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California, EHBs are related to the benefit coverage available in the Kaiser Foundation Health Plan Small 
Group Health Maintenance Organization (HMO) 30 plan, the state’s benchmark plan for federal 
EHBs.21,22 
States may require QHPs to offer benefits that exceed EHBs.23 However, a state that chooses to do so 
must make payments to defray the cost of those additionally mandated benefits, either by paying the 
purchaser directly or by paying the QHP.24,25 State rules related to provider types, cost-sharing, or 
reimbursement methods would not meet the definition of state benefit mandates that could exceed 
EHBs.26  
Table 2 below describes the conditions that would trigger the requirement for the state to defray costs, 
and AB 598’s interaction with each condition. 
Table 2. AB 598 and EHBs 
 
Conditions That Would Trigger 
State to Defray the Cost of a 
Mandate 
Services Mandated by AB 598 
 
Not covered in the Kaiser Small Group 
HMO 30 plan, which is part of the 
definition of the EHB benchmark package 
in California 
Services are not covered in Kaiser Small 
Group HMO 30 plan 
 AB 598 would apply to QHPs in Covered California.  
 
The federal definition of a state benefit 
mandate that can exceed EHBs is 
“specific to the care, treatment, and 
services that a state requires issuers to 
offer to its enrollees.”27 AB 598 would 
appear to meet this federal definition.  
 
 
                                                     
21 The U.S. Department of Health and Human Services (HHS) has allowed each state to define its own EHBs for 
2014 and 2015 by selecting one of a set of specified benchmark plan options. CCIIO, Information on Essential Health 
Benefits Benchmark Plans. Available at: https://www.cms.gov/cciio/resources/data-resources/ehb.html.  
22 H&SC Section 1367.005; IC Section 10112.27. 
23 ACA Section 1311(d)(3). 
24 State benefit mandates enacted on or before December 31, 2011, may be included in a state’s EHBs, according to 
the U.S. Department of Health and Human Services (HHS). Patient Protection and Affordable Care Act: Standards 
Related to Essential Health Benefits, Actuarial Value, and Accreditation. Final Rule. Federal Register, Vol. 78, No. 37. 
February 25, 2013. Available at: www.gpo.gov\fdsys\pkg\FR-2013-02-25\pdf\2013-04084.pdf. 
25 However, as laid out in the Final Rule on EHBs HHS released in February 2013, state benefit mandates enacted 
on or before December 31, 2011, would be included in the state’s EHBs and there would be no requirement that the 
state defray the costs of those state mandated benefits. For state benefit mandates enacted after December 31, 
2011, that are identified as exceeding EHBs, the state would be required to defray the cost. 
26 Essential Health Benefits. Final Rule. A state’s health insurance marketplace would be responsible for determining 
when a state benefit mandate exceeds EHBs, and QHP issuers would be responsible for calculating the cost that 
must be defrayed. 
27 Essential Health Benefits Final Rule. Federal Register, Vol. 87, No. 27. February 25, 2013. Available at: 
www.gpo.gov/fdsys/pkg/FR-2013-02-25/pdf/2013-04084.pdf. 
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Conditions That Would Trigger 
State to Defray the Cost of a 
Mandate 
Services Mandated by AB 598 
 
Pediatric hearing aids and related services 
are not covered under basic health care 
services, as required by the Knox-Keene 
Health Care Service Plan Act of 1975 
 
Source: California Health Benefits Review Program, 2019. 
Notes: (a) California selected Kaiser Small Group HMO 30 as its base EHB benchmark plan, and supplemented this plan with 
pediatric dental and vision benefits, and habilitative services to meet federal requirements. 
(b) Basic health care services are defined by the Knox Keene Health Care Service Plan Act of 1975. 
(c) Federal regulations define benefit mandates that could exceed EHBs as benefits that are specific to care, treatment, and/or 
services. Essential Health Benefits. Final Rule 12843. 
Key: EHB = essential health benefit; HMO = health maintenance organization; QHP = qualified health plan.  
As outlined in the table above, AB 598 would require coverage for a new state benefit mandate that 
appears that it would exceed the definition of EHBs in California. This would appear to trigger the ACA 
requirement that the state defray the cost of additional benefit coverage for enrollees in QHPs in Covered 
California. For more information on potential state costs, refer to Table 4 in the Benefit Coverage, 
Utilization, and Cost Impacts section.   
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BACKGROUND ON HEARING AIDS: MINORS 
Types of Hearing Loss 
There are three types of hearing loss: conductive, sensorineural, and mixed. Sensorineural hearing loss 
occurs when there is damage to the inner ear hair cells or a damaged hearing nerve. Conductive hearing 
loss, affecting the outer ear and middle ear, is usually transient, unlike sensorineural loss, which is 
generally permanent (CDC, 2015a). 
Most permanent hearing loss is sensorineural and is attributed to congenital causes (present at birth) or 
acquired during childhood. About 50% of congenital hearing loss cases are due to genetic causes, 25% 
of cases are due to maternal illness during pregnancy, premature birth, or complications after birth. The 
causes are unknown for the remaining 25% of cases (CDC, 2015b). Reasons for acquired hearing loss 
include excessive noise, injury, certain medications, tumors, jaundice, meningitis, or problems with blood 
circulation (Boyle et al., 2011; Shargorodsky et al., 2010). 
 
 
Source: CDC, 2015a, modified by California Health Benefits Review Program, 2017.  
Hearing loss can range from “mild” to “profound” and can be unilateral or bilateral (one or both ears).  
California Hearing Screening Programs 
California Newborn Hearing Screening Program 
Landmark research in the 1990s found that early identification and treatment of hearing loss in children 
prevented delays in speech, language, and cognitive development, which led to the implementation of the 
universal newborn hearing screening programs (NHSP) in the United States (Yoshinaga-Itano, 2003). 
The California Newborn Hearing Screening Program requires California hospitals to screen newborns for 
hearing loss before discharge (DHCS, 2016). The most recent data (2013) showed that 97% of live births 
in California were screened, and of those, 0.2% (909 infants) were diagnosed with hearing loss by age 6 
months (CDPH, 2015).   
The program’s goal is to identify infants with hearing loss before 3 months of age and subsequently link 
those infants to intervention services by 6 months of age (DHCS, 2016). Infants who fail the initial 
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screening in the hospital setting are referred for up to two more rescreenings prior to 3 months of age. 
Those who do not pass the final screening are referred to California Children’s Services for a diagnostic 
hearing evaluation. In addition to screening and diagnosis for hearing loss, the NHSP connects families of 
newly diagnosed infants with community support services (including services provided based on the 
requirements of the Individuals with Disabilities Education Act), assists with assessing the family’s 
insurance coverage or, if eligible, facilitates enrollment in the California Children Services and Early Start 
Programs (DHCS, 2016).  
Public School Hearing Screening Programs 
Public screening programs for hearing loss in school-aged children also identify those with previously 
undiagnosed loss and acquired hearing loss. Specifically, California requires school-aged children to be 
screened in kindergarten or first grade, second, fifth, eighth, and tenth or eleventh grade. School 
audiometrists, public health nurses, or credentialed school nurses conduct the screenings. If a child fails 
the hearing test, the school must provide to the parents or guardians a written notice of the results and 
provide a recommendation for medical and audiological follow-up evaluations. 
Prevalence and Incidence of Hearing Loss in California 
National 
According to the Centers for Disease Control and Prevention, estimating the total number of children with 
hearing loss is dependent on the age groups studied and the definition of hearing loss (CDC, 2015c). 
Various national surveys28 and programs track the incidence29 and prevalence30 of children with hearing 
loss using different age groups (e.g., cohorts of newborns, aged 8 years, aged 3 to 17 years); different 
definitions (e.g., moderate-to-profound loss, affected by hearing loss), and different methods (e.g., self-
report, administrative records, audiometric evaluations) (Mehra et al., 2009). These differences make it 
difficult to calculate an overall prevalence rate for children under age 19 years. The literature frequently 
notes that the incidence of moderate-to-profound pediatric hearing loss ranges between 1 and 5 per 
1,000 children (0.1% to 0.5%) (Boyle et al., 2011; HLAC, 2016; NIDCD, 2016). Other sources report 
prevalence rates between 3.1% to 5.3% and up to 15% of children (aged 6 to 19 years and 12 to 19 
years, respectively) with a hearing loss of at least 16 dB (slight loss) in one or both ears (Niskar et al., 
1998; Shargorodsky et al., 2010) (Table 1).  
California 
CHBRP found no registry or recent survey data that estimated overall hearing loss in California’s pediatric 
population, but the CDC Early Hearing and Detection Intervention program showed an incidence rate of 
1.9 per 1,000 California newborns screened in 2013 with hearing loss (reported via California NHSP). 
Additionally, there are several state agencies that provide services to support many of California’s 
children with hearing loss including the California Department of Developmental Services (serving about 
3,512 children with “hearing problems”) and the California Department of Education (serving about 
16,15031 “hard of hearing/deaf” children) (CDE, 2016; DDS, 2016).   
                                                     
28 National Health and Nutrition Examination Survey (NHANES III), Metropolitan Atlanta Developmental Disabilities 
Surveillance Program, National Health Information Survey, Early Hearing Detection and Intervention Program, etc.  
29 Incidence is the number of new cases identified in a specified timeframe (e.g., number of new cases of flu in 
August). 
30 Prevalence is the number of all active cases identified in a specific timeframe (e.g., all cases of flu in August). 
31 Personal communication, N. Sager, March 2016. 
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Children may experience hearing loss in one or both ears, and so will require either one or two hearing 
aids. CHBRP finds the following prevalence estimate most relevant to the analysis of AB 598: Nationwide, 
hearing loss in one ear (unilateral) occurs in about 2.7% of adolescents aged 12 to 19 while hearing loss 
in both ears (bilateral) is less common at 0.8% of adolescents (Shargorodsky et al., 2010). This overall 
prevalence rate of 3.5% includes children with unilateral and bilateral loss of at least 16 dB that is 
congenital or acquired.  
Types and Costs of Hearing Aids 
Costs and Ability to Pay 
Hearing aids generally cost between $1,500 and $4,000 per ear depending on the technology and 
enhancements selected by the patient. Patients also incur costs for hearing aid-related services such as 
fittings, repairs, and related audiometry testing. Families of children with hearing loss experience 
additional costs associated with more frequent fittings of new ear molds necessary to accommodate the 
child’s growth (up to 4 times per year for infants/toddlers32). Muñoz et al. (2013) reported that the most 
important challenges to parents in obtaining pediatric hearing aids was the ability to pay, accepting the 
need for hearing aids, and wait time for a pediatric audiologist. Their 2007 to 2010 survey results 
indicated that, despite the cost challenge, only a minority of parents were unable to obtain hearing aids 
for their child (4 of 333 respondents, or 1.2%). Thirty-seven percent reported having insurance coverage 
for hearing aids and about one-half of children were fitted with loaner hearing aids prior to purchasing 
their own (California does not have a hearing aid loaner program unlike Colorado, Idaho, or Kansas; 
however, some hearing aid manufacturers provide the loaner service) (Muñoz et al., 2013). Other sources 
of hearing aid assistance, for those who meet eligibility criteria, include charities and California Children’s 
Services33 (Muñoz et al., 2013).   
In summary, cost may pose a final barrier wherein a minority of children who need hearing aids go 
without hearing aids because they cannot afford them. In other cases, families may shoulder a financial 
burden to acquire medically necessary hearing aids for children. 
Types of Hearing Aids 
There are five basic categories of hearing aids (Table 3), all of which are customized for each user by the 
manufacturer and audiologist. Due to improved technology, the electronics used in hearing aids are 
usually digital rather than analog;34 however, either can be used in any type of hearing aid. In general, 
hearing aids include a microphone, amplifier, receiver, and battery (volume controls are optional, and can 
be activated or de-activated in the programming software (American Hearing Research Foundation, 
2015). Digital aids convert sound waves into numerical codes (i.e., binary code) before amplifying them. 
The coding allows the audiologist to program the aid to accommodate a variety of types, degrees, and 
configurations of hearing and to help the user hear and understand in a variety of settings (i.e., 
classrooms, noisy restaurants, etc.). Digital aids also have the ability to focus on sounds coming from a 
specific direction (NIDCD, 2015). 
                                                     
32 Personal communication, M. Winter, March 2016. 
33 http://www.dhcs.ca.gov/services/ccs/Pages/qualify.aspx.  
34 Personal communication, M. Winter, March 2016. 
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Hearing aid fittings 
Children who are prescribed hearing aids visit an audiologist who works with the child’s parents or 
guardians to select an appropriate hearing aid. The type of insurance coverage for hearing aids, if any, 
may impact the type of hearing aid they select. The audiologist takes impressions of the child’s ears to 
make custom ear molds for the child’s hearing aid. After the hearing aid is selected and ordered, the child 
returns for a fitting. This requires taking measurements of the child’s ear canal volume, programming the 
hearing aids using manufacturer software, and adjusting the hearing aid to the child’s ear canal volume, 
verifying the amplification to appropriate target values and validation of the fitting through observation, 
questionnaires, assessment of sound detection and speech comprehension. For young children, hearing 
aid checks and assessments are needed frequently with ear molds being recast three to four times per 
year). When children are well established with a stable hearing and amplification, they are likely to need 
checks and assessments about twice annually, and adolescents are likely to need annual checks.  
Table 3. Description of Categories of Hearing Aids 
Type of Aid Description $ Range* 
BTE:  
Behind-the-ear 
 
Hard plastic cases that fit behind the ear and connect by tubing 
to a plastic customized ear mold that fits into the outer ear. Least 
expensive, easiest to adjust, less feedback, fewest problems 
with wax or infections. Suitable for mild-to-profound hearing loss. 
 
BTE are considered the most appropriate hearing aid for young 
children since they accommodate the widest range of loss, and, 
since as the child grows, ear molds can be replaced frequently 
without having to re-case an in-the-ear instrument. 
 
$1,580–$2,769 
RIC/RITE: 
Receiver in 
canal/Receiver-
in-the ear 
Similar in appearance to BTE, but the speaker is placed inside 
the canal via thin wires instead of acoustic tubes. Suitable for 
mild to severe loss. Controls are easy to manipulate. Wax and 
moisture build up may occur, and users may feel “plugged” while 
wearing. May be appropriate for children since ear molds can be 
recast as the child grows.  
 
$1,694–$2,993 
ITE:  
In-the-ear  
The aid, contained in a custom shell, fits in outer ear bowl and 
part of the ear canal. They are suitable for mild-to-severe 
hearing loss. Low-profile hearing aids are described as half-shell 
shapes that fit in the lower half of the outer ear and are large 
enough to accommodate volume wheels and program push 
buttons. Requires dexterity to adjust and remove; not 
recommended for young children who would require new custom 
shells to assure proper fit as they grow. 
 
$1,600–$2,757 
ITC/CIC:  
In-the-canal/ 
Completely-in-
canal 
Fits entirely inside the canal. The least visible aids are 
completely-in-the-canal (CIC). These are very small and can be 
hard for some people to adjust and remove. Both can be used 
for mild-to-moderately severe hearing loss and are generally not 
recommended for young children or people with severe-to-
profound hearing loss due to limited power and volume and 
because the smallest aids can be a choking hazard for infants 
and toddlers.   
 
$1,695–$2,958 
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Type of Aid Description $ Range* 
BCHA: Bone 
conduction 
hearing aid 
Vibratory transducer is attached to a removable headband and 
presses through the scalp against the skull bone to transmit 
vibrations (sound waves) via bone to the inner ear.   
 
Ideal candidates are children with aural atresia (structural 
deficits to middle ear), absent external ears, chronic middle ear 
drainage, or unilateral profound sensorineural hearing loss 
where conventional hearing aids are contraindicated and who 
are too young for surgical application of bone conduction 
implants. 
 
$4,000 
Sources: California Health Benefits Review Program, 2016. Photos from American Speech-Language-Hearing 
Association. Descriptions from the American Hearing Research Foundation, NIDCD, and personal communication 
with M. Winter.  
Note: Extended Wear Hearing Aids are another newer option for adults. They are placed nonsurgically in the ear 
canal by an audiologist and worn continuously for several months until replaced with a new aid. 
* Estimated range in costs obtained from AARP Hearing Aid Styles: Pros and Cons (Gandel, 2014), and personal 
communication with M. Winter, April 5, 2016 (for BCHA estimate). 
Social Determinants of Health35 and Disparities36 in Hearing Loss 
Per statute, CHBRP includes discussion of disparities under the broader umbrella of social determinants 
of health (SDoH). SDoH include factors outside of the traditional medical care system that influence 
health status and health outcomes. CHBRP considers the full range of SDoH and related disparities (e.g., 
income, education, and social construct around age, race/ethnicity, gender, and gender identity/sexual 
orientation) that are relevant to this bill and where evidence is available. In the case of AB 598, evidence 
shows that disparities exist in the prevalence of pediatric hearing loss by gender and race/ethnicity in 
addition to disparities in the prevalence of obtaining screening for hearing loss by geographic location and 
educational attainment. No data were found regarding the utilization of hearing aids in the pediatric 
population by race/ethnicity or gender.  
Disparities in Pediatric Hearing Loss 
CHBRP reviewed several sources to identify potential disparities in the prevalence of pediatric hearing 
loss. The 2005–2006 National Health and Nutrition Examination Survey (NHANES) used interviews and 
performed audiometric evaluations on children aged 12 to 19 years to determine level of hearing loss 
(moderate to profound) in the pediatric cohort. The National Health Interview Survey (NHIS) included a 
nationally representative cohort of children aged 3 to 17 years to estimate the prevalence of moderate-to-
profound hearing loss. The NHIS data presented here are aggregated between 1991 and 2008 (Boyle et 
al., 2011). The 2010 Metropolitan Atlanta Developmental Disabilities Surveillance Program (MADDSP) 
                                                     
35 CHBRP defines social determinants of health as conditions in which people are born, grow, live, work, learn, and 
age. These social determinants of health (economic factors, social factors, education, physical environment) are 
shaped by the distribution of money, power, and resources and impacted by policy (adapted from CDC, 2014; 
Healthy People 2020 [ODPHP, 2016). See SDoH white paper for further information. Available at: 
http://www.chbrp.org/analysis_methodology/docs/Incorporating%20Relevant%20Social%20%20Determinants%20of
%20Health%20in%20CHBRP%20Analyses%20Final%2003252016.pdf. 
36 Several competing definitions of “health disparities” exist. CHBRP relies on the following definition: 
“Health disparities are potentially avoidable differences in health (or health risks that policy can influence) between 
groups of people who are more or less advantaged socially; these differences systematically place socially 
disadvantaged groups” at risk for worse health outcomes (Braveman, 2006). 
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monitored only children aged 8 years using administrative data from multiple education and health 
records and reported on those with moderate-to-profound hearing loss (Van Naarden Braun et al., 2015). 
Gender 
Most studies found that pediatric hearing loss is more prevalent among males than females (Mehra et al,, 
2009). For example, a study using NHIS data found that the prevalence of self-reported moderate-to-
profound pediatric hearing loss in males was 0.42% compared with 0.35% in females (Boyle et al., 2011). 
A study using MADDSP data on 8-year-olds in the Atlanta region reported a mean hearing loss 
prevalence rate of 1.5% for males compared with 1.2% for females between 1991 and 2010. And 
Shargorodsky et al. (using NHANES data) reported that among 12- to 19-year-olds, hearing loss among 
males was 21.8% compared to females at 17.1%. The NHANES study included those with a slight 
hearing loss (16 dB or greater) rather than moderate or greater loss, and focused on older children who 
would have higher rates of acquired loss, thus, the discrepancy between studies. 
Income 
Boyle et al. (2011) found that a higher proportion of children who were poor and who were covered by 
public insurance suffered from hearing loss, but that the differences were not statistically significant. For 
instance, the prevalence of moderate-to-profound hearing loss in children living below 200% FPL37 was 
0.47% compared with 0.32% for those at or above 200% FPL. Additionally, hard of hearing children with 
private insurance had the lowest prevalence rate of hearing loss (0.34%), followed by those who were 
uninsured (0.44%). Those who had Medicaid/Children's Health Insurance Program (CHIP) insurance had 
the highest rate of hearing loss (0.77%) (Boyle et al., 2011). These findings are from the National Health 
Interview Survey using parent reports of their child’s moderate-to-profound hearing loss. Although there is 
no explanation of why rates may be higher in poor children, the same pattern was found in the distribution 
of ADHD (attention-deficit/hyperactivity disorder), learning disabilities, intellectual disabilities, seizures, 
and other developmental delays included in the study.  
Race/ethnicity 
CHBRP found ambiguous evidence about racial/ethnic disparities in the prevalence of pediatric hearing 
loss. Two studies reported that prevalence rates of moderate-to-profound hearing loss was lowest among 
Hispanics (Boyle et al., 2011; Shargorodsky et al., 2010). One study showed non-Hispanic whites with a 
higher prevalence of pediatric hearing loss than non-Hispanic blacks (0.44% and 0.35%, respectively) 
(Boyle et al., 2011), whereas two other studies found no significant difference between the two groups 
(Shargorodsky et al., 2010; Van Naarden Braun et al., 2015). 
Disparities in Obtaining Medical Services for Hearing Loss 
CHBRP considers both disparities in health conditions, such as hearing loss, as well as disparities in 
obtaining medical services to treat identified health conditions. In this case, those with hearing loss would 
need to be screened and diagnosed in order to receive a hearing aid. Thus, CHBRP conducted a 
literature review to examine the extent to which there are disparities in receipt of hearing screenings or 
receipt of hearing aids. CHBRP found limited evidence regarding the types of barriers facing families in 
obtaining screening for hearing loss followed by the management of hearing loss and acquisition of 
hearing aids for children in need. Bush et al. (2014) found that there are regional socioeconomic and 
educational disparities in the timely diagnosis of congenital hearing loss in rural children and concluded 
that there may be a number of rural socioeconomic variables contributing to noncompliance with 
                                                     
37 FPL = Federal Poverty Level. 
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treatment and diagnostic factors, including limited availability of infant diagnostic audiological services, 
longer average commute times to seek health care services (1 to 3 hours), lack of public transit, and 
geographic isolation. In a systematic review conducted by Ravi et al. (2016), 25 of 53 studies reported 
disparities in education and lack of adequate knowledge as a leading contributor of familial 
noncompliance and loss to follow-up for hearing loss management. To date, there have been no studies 
conducted that review and evaluate disparities in obtaining hearing aids. However, it stands to reason 
that disparities in obtaining screening for hearing loss would transfer to disparities in obtaining hearing 
aids. Although it is important to note that coverage of hearing aids through the Medi-Cal program in 
California may reduce disparities by eliminating financial barriers for low-income children, Medi-Cal 
coverage would not address other barriers such as lack of education or geographic location listed above. 
The presence of hearing loss in California/the United States creates a societal impact. In dollar terms, the 
societal impact can be indirect (lost wages, etc.) as well as direct (medical care, etc.). CHBRP is unable 
to find data that displays the larger societal impact of hearing loss specifically. The Benefit Coverage, 
Utilization, and Cost Impacts section estimates cost impacts on payers, including enrollees. Such figures 
represent a subset of the total societal impact related to hearing loss. 
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MEDICAL EFFECTIVENESS 
Because CHBRP completed a literature review in 2016 for a very similar bill, AB 2004 (Bloom) Hearing 
Aids: Minors, CHBRP did not complete an entirely new literature review in 2017 for AB 1601 and for AB 
598 in 2019. CHBRP assumed that the literature in this field is unlikely to have changed significantly in 
the past 2 years38, which was confirmed by an abbreviated literature search for medical literature on this 
subject published since 2017. Outcomes addressed in 2016’s AB 2004 literature review include: 
• Speech Outcomes; 
• Language Development; 
• Nonverbal Outcomes; 
• Personal/Social Development Outcomes; 
• Effectiveness of Using a Hearing Aid With Cochlear Implant Summary; and  
• Effectiveness of Using a Wearable BCHA. 
In this section, CHBRP presents a summary of the 2016 literature review results. For the full Medical 
Effectiveness section and literature review results, please see the AB 2004 CHBRP report (CHBRP 
Completed Analyses).  
Interventions to treat hearing loss in children involve fitting children with hearing aids and providing 
educational interventions for children and their caregivers. Hearing aids help children with hearing loss by 
amplifying sounds. In the United States, the federal Individuals with Disabilities Education Act (IDEA) 
requires local school districts to provide educational interventions to children with hearing loss. These 
interventions include training in the use of hearing aids and auditory, speech, and language development. 
Families of children with hearing loss are often given counseling and training in stimulation of speech and 
communication. 
Interventions may also include sign language training. Most intervention programs for hearing loss among 
young children provide a combination of home- and school-based services (Carney and Moeller, 1998). 
Research Approach and Methods 
CHBRP’s medical effectiveness review for AB 1601 built upon the review conducted by CHBRP for AB 
368 (2007) and includes studies published from 2006 to 2016. The search was limited to studies of 
children with hearing loss because the three bills analyzed since 2016 would require health plans to cover 
hearings aids only for children and because characteristics of hearing loss in children and adults differ 
(CHBRP, 2007). The CHBRP medical effectiveness reviews focus on traditional air conduction hearing 
aids because they are the type of hearing aids most frequently used by children with hearing loss 
(Gabbard and Schryer, 2003; Palmer and Ortmann, 2005).39 A more thorough description of the methods 
                                                     
38 Further discussion of this rationale is included in the Methodological Considerations section. 
39 In the 2016 literature review, CHBRP searched for more current data on the types of hearing aids used by children 
but did not identify any more recent studies. 
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used to conduct the medical effectiveness review and the process used to grade the evidence for each 
outcome measure may be found in Appendix B of the AB 2004 Report (CHBRP Completed Analyses).  
Methodological Considerations 
It is generally accepted that the use of hearing aids improves the hearing of children with hearing loss. As 
a result, there have been few recent studies on the impact of hearing aids on hearing in children. As 
noted, the current review builds upon the review conducted by CHBRP for AB 368 (2007); key findings of 
studies noted previously are summarized, and more current literature is included where available. The 
review examines three major categories of recent studies on children with hearing loss: (1) studies of the 
relationship between age at initial diagnosis and treatment of hearing loss, and children’s speech, 
language, and social development; (2) studies of the effect of wearing a hearing aid in the opposite ear 
from a cochlear implant, and (3) studies of wearable BCHAs. 
The literature review did not discover any randomized controlled trials (RCTs) of children with hearing 
loss that assess the effects of early diagnosis and treatment of hearing loss, or the effectiveness of using 
a hearing aid in the opposite ear from a cochlear implant, or wearable BCHA. The barriers to conducting 
RCTs of hearing loss treatments for children are formidable, resulting in a research base that is not as 
rigorous and thereby limiting the certainty of conclusions drawn from the literature. All of the studies of the 
effectiveness of early diagnosis and treatment were observational studies that did not include control 
groups of children with hearing loss who did not receive hearing aids or other interventions. 
Outcomes Assessed 
CHBRP’s review of the literature on the effects of hearing aids on children with hearing loss suggests that 
early treatment of hearing loss is associated with improvement in language, verbal, nonverbal, and social 
development outcomes. These findings relate to AB 598, because if health plans cover hearing aids for 
children, more children may have access to hearing aids at a younger age.  
Findings for Quality of Life in Children 
Speech outcomes 
The 2007 CHBRP review found a preponderance of evidence suggesting that early diagnosis and 
treatment of hearing loss decreases the age at which children begin to form syllables and improves the 
intelligibility of their speech.  
CHBRP found no recent studies examining the effect of hearing aids on speech outcomes in children. 
The preponderance of evidence from moderate research designs suggests that early treatment of hearing 
loss by hearing aids is effective in improving speech outcomes in children.  
Language development outcomes 
The 2007 CHBRP report on hearing aids in children described several studies that assessed the impact 
of early treatment of hearing loss via hearing aids on language development outcomes. CHBRP found a 
preponderance of evidence that children treated for hearing loss at a younger age had statistically 
significant improvement in receptive vocabulary and verbal reasoning compared to children at later 
stages that did not have statistically significant language development outcomes. The report also cites 
studies demonstrating that children fitted with hearing aids at younger ages had significantly larger 
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vocabularies, asked a significantly higher proportion of questions in conversation, and spoke significantly 
more words per minute as measured by one of two instruments.  
CHBRP identified two more recent studies (Tomblin et al., 2014, 2015) that found mild-to-severe hearing 
loss places children at risk for delays in language development, but those risks are moderated by the 
provision of early and consistent access to well-fit hearing aids that provide optimized audibility. 
Overall, the preponderance of evidence suggests that early diagnosis and treatment of hearing loss 
improves language development. 
Nonverbal interaction outcomes 
Three studies identified by CHBRP in 2007 demonstrated an association between early diagnosis of 
hearing loss and treatment and more advanced nonverbal interactions (such as observation, imitation, 
discrimination among objects, and motor behavior) for children with hearing aids, although two out of 
three of these studies’ observations were not statistically significant. 
CHBRP found no recent studies examining the effect of hearing aids on nonverbal interaction in children. 
Thus, there is a preponderance of evidence suggests that early diagnosis and treatment are associated 
with small, nonsignificant gains in nonverbal understanding and interaction. 
Personal/social development outcomes 
In 2007, CHBRP identified several studies with a lack of significant and consistent findings investigating 
the effects of age at intervention to treat hearing loss on children’s personal and social development.  
CHBRP found no recent studies examining the effect of hearing aids on personal and social development 
in children.   
The lack of significant and consistent findings indicates that the evidence of effect of early diagnosis and 
treatment of hearing loss on personal/social development is conflicting. Please note that the absence of 
evidence is not “evidence of no effect” — positive or negative impacts could result, but current evidence is 
insufficient to ascertain outcomes. 
Findings for Hearing Aid Use With Cochlear Implants and Wearable BCHA 
Studies of the effects of using a hearing aid in the opposite ear from a cochlear implant 
Cochlear implants are used by children with severe-to-profound hearing loss that have one or more ears 
in which hearing is too poor to derive benefit from a hearing aid. Whereas a hearing aid amplifies sounds 
to improve the ear’s ability to hear them, a cochlear implant bypasses the damaged portions of the ear 
and directly stimulates the auditory nerve. Cochlear implants consist of an implanted electrode array that 
is attached to an external device that amplifies sound, processes speech, stimulates the auditory nerve, 
and transmits signals to the implanted electrode array. Children who receive cochlear implants must 
undergo extensive speech therapy because the process of hearing with a cochlear implant differs from 
normal hearing or using a hearing aid (NIDCD, 2006). 
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The 2007 CHBRP report found several studies that assessed the impact of using a hearing aid in the 
opposite ear from a cochlear implant.40 These studies are pertinent to AB 593 because having health 
insurance coverage for hearing aids may increase the likelihood that children with cochlear implants 
would be fitted with a hearing aid in the opposite ear. Several previous studies found that using a hearing 
aid with a cochlear implant was associated with a statistically significant improvement in speech 
recognition (Ching et al., 2001, 2005; Holt et al., 2005). By contrast, one study reported that using a 
hearing aid with a cochlear implant had no effect on speech recognition, but instead found that bilateral 
cochlear implants were associated with better speech recognition than were unilateral cochlear implants 
(Litovsky et al., 2006).  
Overall, the preponderance of the evidence suggests that using a hearing aid with a cochlear implant 
improves speech recognition, but may not be as effective as bilateral cochlear implants for children who 
are candidates for bilateral cochlear implants. CHBRP found no recent studies examining the effect of 
using a hearing aid in the opposite ear from a cochlear implant on speech recognition. 
Studies of the effects of using wearable BCHA 
The wearable bone conduction hearing aid (BCHA) is an alternative to the surgically implanted BCHA for 
children that are too young for an implant because the thickness of the temporal bone is too small and 
because of problems with osseo-integration of the titanium implant in the immature bone (Verhagen et al., 
2008). CHBRP interprets AB 593 to require health plans to cover wearable BCHAs because they are 
external, wearable devices. 
CHBRP found two cohort studies conducted outside of the United States that evaluated the effects of 
wearable BCHAs for children with bilateral aural atresia (failure of the development of the external 
auditory canal in both ears, such that it cannot accommodate a standard hearing aid). The studies found 
that the wearable BCHA is as effective for hearing rehabilitation and auditory development (Fan et al., 
2014; Verhagen et al., 2008). One study found the wearable BCHA to be as effective as the conventional 
bone conductor with a spring clamping steel headband (Verhagen et al., 2008). Neither study assessed 
adverse effects associated with use of the wearable BCHA. Further limitations of these studies include 
low statistical power due to small sample sizes, and limited data assessing language development 
outcomes (Verhagen et al., 2008).  
Study Findings 
CHBRP’s review of the literature on the effects of hearing aids on children with hearing loss suggests that 
early treatment of hearing loss is associated with improvement in language, verbal, nonverbal, and social 
development outcomes. These findings relate to AB 598, because if health plans cover hearing aids for 
children, more children may have access to hearing aids at a younger age.  
                                                     
40 The 2007 report for AB 368 also summarizes studies related to the effect of using a hearing aid in conjunction with 
a cochlear implant on the localization of sound, and impact of using a hearing aid in conjunction with a cochlear 
implant on children’s functional performance during activities of daily living. Though evidence for improvement in 
localization was ambiguous, CHBRP found that use of a hearing aid in conjunction with a cochlear implant is effective 
at improving functional performance during activities of daily living. 
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Findings for Quality of Life in Children 
Speech outcomes 
The 2007 CHBRP review found a preponderance of evidence suggesting that early diagnosis and 
treatment of hearing loss decreases the age at which children begin to form syllables and improves the 
intelligibility of their speech.  
CHBRP found no recent studies examining the effect of hearing aids on speech outcomes in children. 
The preponderance of evidence from moderate research designs suggests that early treatment of hearing 
loss by hearing aids is effective in improving speech outcomes in children.  
Nonverbal interaction outcomes 
Three studies identified by CHBRP in 2007 demonstrated an association between early diagnosis of 
hearing loss and treatment and more advanced nonverbal interactions (such as observation, imitation, 
discrimination among objects, and motor behavior) for children with hearing aids, although two out of 
three of these studies’ observations were not statistically significant. 
CHBRP found no recent studies examining the effect of hearing aids on nonverbal interaction in children. 
Thus, there is a preponderance of evidence suggests that early diagnosis and treatment are associated 
with small, nonsignificant gains in nonverbal understanding and interaction. 
Personal/social development outcomes 
In 2007, CHBRP identified several studies with a lack of significant and consistent findings investigating 
the effects of age at intervention to treat hearing loss on children’s personal and social development.  
CHBRP found no recent studies examining the effect of hearing aids on personal and social development 
in children.   
The lack of significant and consistent findings indicates that the evidence of effect of early diagnosis and 
treatment of hearing loss on personal/social development is conflicting. Please note that the absence of 
evidence is not “evidence of no effect” — positive or negative impacts could result, but current evidence is 
insufficient to ascertain outcomes. 
Findings for Hearing Aid Use With Cochlear Implants and Wearable BCHA 
Studies of the effects of using a hearing aid in the opposite ear from a cochlear implant 
Cochlear implants are used by children with severe-to-profound hearing loss that have one or more ears 
in which hearing is too poor to derive benefit from a hearing aid. Whereas a hearing aid amplifies sounds 
to improve the ear’s ability to hear them, a cochlear implant bypasses the damaged portions of the ear 
and directly stimulates the auditory nerve. Cochlear implants consist of an implanted electrode array that 
is attached to an external device that amplifies sound, processes speech, stimulates the auditory nerve, 
and transmits signals to the implanted electrode array. Children who receive cochlear implants must 
undergo extensive speech therapy because the process of hearing with a cochlear implant differs from 
normal hearing or using a hearing aid (NIDCD, 2006). 
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The 2007 CHBRP report found several studies that assessed the impact of using a hearing aid in the 
opposite ear from a cochlear implant.41 These studies are pertinent to AB 598 because having health 
insurance coverage for hearing aids may increase the likelihood that children with cochlear implants 
would be fitted with a hearing aid in the opposite ear. Several previous studies found that using a hearing 
aid with a cochlear implant was associated with a statistically significant improvement in speech 
recognition (Ching et al., 2001, 2005; Holt et al., 2005). By contrast, one study reported that using a 
hearing aid with a cochlear implant had no effect on speech recognition, but instead found that bilateral 
cochlear implants were associated with better speech recognition than were unilateral cochlear implants 
(Litovsky et al., 2006).  
Overall, the preponderance of the evidence suggests that using a hearing aid with a cochlear implant 
improves speech recognition, but may not be as effective as bilateral cochlear implants for children who 
are candidates for bilateral cochlear implants. CHBRP found no recent studies examining the effect of 
using a hearing aid in the opposite ear from a cochlear implant on speech recognition. 
Studies of the effects of using wearable BCHA 
The wearable BCHA is an alternative to the surgically implanted BCHA for children that are too young for 
an implant because the thickness of the temporal bone is too small and because of problems with osseo-
integration of the titanium implant in the immature bone (Verhagen et al., 2008). CHBRP interprets AB 
598 to require health plans to cover wearable BCHAs because they are external, wearable devices. 
CHBRP found two cohort studies conducted outside of the United States that evaluated the effects of 
wearable BCHAs for children with bilateral aural atresia (failure of the development of the external 
auditory canal in both ears, such that it cannot accommodate a standard hearing aid). The studies found 
that the wearable BCHA is as effective for hearing rehabilitation and auditory development (Fan et al., 
2014; Verhagen et al., 2008). One study found the wearable BCHA to be as effective as the conventional 
bone conductor with a spring clamping steel headband (Verhagen et al., 2008). Neither study assessed 
adverse effects associated with use of the wearable BCHA. Further limitations of these studies include 
low statistical power due to small sample sizes, and limited data assessing language development 
outcomes (Verhagen et al., 2008).  
Summary of Findings 
The figures in this section summarize CHBRP’s findings regarding the strength of the evidence for the 
effects of specific tests, treatments, and services addressed by AB 598. Separate charts are presented 
for each test, treatment, or service for which the bill would mandate coverage and for each outcome for 
which evidence of the effectiveness of a treatment is available. The title of the chart indicates the test, 
treatment or service for which evidence is summarized. The statement under the heading “Conclusion” 
presents CHBRP’s conclusion regarding the strength of evidence about the effect of a particular test, 
treatment, or service on a specific relevant outcome and the number of studies on which CHBRP’s 
conclusion is based. For test, treatments, and services for which CHBRP concludes that there is clear 
and convincing, preponderance, limited, or conflicting evidence, the placement of the vertical bar 
indicates the strength of the evidence. If CHBRP concludes that evidence is insufficient, a graph that 
states “Insufficient Evidence” will be presented. 
                                                     
41 The 2007 report for AB 368 also summarizes studies related to the effect of using a hearing aid in conjunction with 
a cochlear implant on the localization of sound, and impact of using a hearing aid in conjunction with a cochlear 
implant on children’s functional performance during activities of daily living. Though evidence for improvement in 
localization was ambiguous, CHBRP found that use of a hearing aid in conjunction with a cochlear implant is effective 
at improving functional performance during activities of daily living. 
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Figure 1. Speech Outcomes Summary 
CHBRP concludes that there is a preponderance of evidence from studies with moderately strong 
research designs that suggests that earlier age of fitting with hearing aid is associated with greater gains 
in speech outcomes. The reason for a rating of moderate is due to a lack of studies with strong research 
designs (e.g., RCTs). 
 
 
Figure 2. Language Development Outcomes Summary 
CHBRP concludes that there is a preponderance of evidence from studies with moderately strong 
research designs that hearing aids are effective in improving language development outcomes in 
children. In particular, risk for language delays in children with hearing loss may be mitigated from early 
age of fitting and consistent use of hearing aids. The reason for a rating of moderate is due to a lack of 
studies with strong research designs (e.g., RCTs).  
 
 
Figure 3. Nonverbal Outcomes Summary 
CHBRP concludes that there is a preponderance of evidence that suggest hearing aids are effective in 
improving nonverbal outcomes in children.  
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Figure 4. Personal/Social Development Outcomes Summary 
CHBRP concludes that there is conflicting evidence that hearing aids are effective in improving 
personal and social development outcomes in children. CHBRP notes that the absence of conclusive 
evidence does not mean there is no effect; it means the effect is unknown.  
 
 
Figure 5. Effectiveness of Using a Hearing Aid With Cochlear Implant Summary 
CHBRP concludes that there is a preponderance of evidence that hearing aid use with a cochlear 
implant improves outcomes for children, but may not be as effective as bilateral cochlear implants for 
children who are candidates for bilateral cochlear implants.   
 
 
Figure 6. Effectiveness of Using a Wearable BCHA 
CHBRP concludes that there is a preponderance of evidence from studies with moderate designs that 
suggest the wearable BCHA is effective for hearing rehabilitation and auditory development.  
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BENEFIT COVERAGE, UTILIZATION, AND COST IMPACTS 
As discussed in the Policy Context section, AB 598 would require DMHC-regulated health plans and CDI-
regulated policies to provide coverage of hearing aids for children aged 0 to 17 years, as well as publicly 
funded plans (including CalPERS and Medi-Cal Managed Care Plans that are subject to the Knox-Keene 
Health Care Service Plan Act). CHBRP determined current coverage of hearing aids for children aged 0 
to 17 by relying upon the survey of the seven largest providers of health insurance in California performed 
for a substantially similar bill AB 2004 (2016). 
All hearing aid service product codes were identified with the assistance of a content expert. The 
following were excluded as they identify services not covered by AB 598: cochlear implants, battery and 
cord replacements, and hearing screening. Hearing aid product codes (HCPCs) were used to extract data 
from Truven’s MarketScan® Commercial Claims and Encounters Database (‘MarketScan’) and the 
Milliman Consolidated Health Cost Guidelines Sources Database (‘CHSD’). For this analysis, CHBRP 
includes the following types of hearing aids: 
• Behind-the-ear (BTE); 
• Receiver in canal/receiver-in-the ear (RIC/RITE); 
• In-the-ear (ITE); 
• In-the-canal/completely-in-canal (ITC/CIC); and 
• Wearable (non-surgically implanted) bone conduction hearing aid (BCHA). 
Because all children already qualify for initial assessment hearing screening under the California 
Newborn Screening Hearing Program and school-age screening, costs associated with screening were 
excluded from the bill analysis (ASHA, 2019). The 2016 MarketScan and CHSD data were used to 
develop baseline cost and utilization information for hearing aids for 0- to 17-year-olds. CHBRP identified 
four categories of hearing aid services within the claims data: 
• Hearing aids; 
• Maintenance and repairs (excludes ear molds); 
• Diagnostic tests, hearing aid checks, fittings and adjustments (excludes screening as part of initial 
assessment as these are already covered under EHB); and 
• Ear molds. 
From these claims databases, utilization and unit cost information were identified for each service 
category. Where coverage is not offered by the health plan, the enrollee is responsible for the cost of 
hearing aids, which is a likely barrier to utilization. This removal of financial responsibility for the full cost 
of hearing aids when pediatric hearing aids coverage is introduced might thus result in utilization uptake. 
There are, however, no data sources that show by how much hearing aid utilization increases when 
coverage for hearing aids is mandated; in other words, there have not been longitudinal studies 
examining changes in utilization before and after legislation has been implemented in other states. 
CHBRP thus used content expert input and information in the peer-reviewed literature to estimate likely 
utilization change that the demand for hearing aids among children is largely price inelastic (see 
Postmandate Utilization below and Appendix C for more detail), which means families are not likely to 
forgo obtaining hearing aids for their children due to cost and there are programs, such as CCS and 
charities, available to families meeting financial requirements. With the body of evidence available, 
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CHBRP estimates that the removal of a cost barrier when coverage is introduced for hearing aids would 
thus result in a modest increase in utilization of 2.4% among enrollees who do not have coverage for 
hearing aids and related services premandate. Separate from utilization change due to cost, and not to be 
overlooked, is that cost of hearing aids and services has been shown to pose a financial burden to 
families obtaining hearing aids (Limb et al., 2010; Muñoz et al., 2013). The financial load that is lifted off 
of families when coverage for hearing aids is offered by carriers is seen in the estimates of out-of-pocket 
expenditures for hearing aids and services presented in this section and discussed in greater detail in the 
Public Health Impacts section. Enrollees, including those eligible for CCS, may shift to more costly 
hearing aids in the absence of financial burden. However, existing insurer practices such as coverage 
caps and cost-sharing levels are likely to prevent a higher level of utilization of more costly units 
postmandate. 
This section reports the potential incremental impact of AB 598 on estimated baseline benefit coverage, 
utilization, and overall cost. For further details on the underlying data sources and methods used in this 
analysis, please see Appendix C.  
Baseline and Postmandate Benefit Coverage 
Premandate (Baseline) Benefit Coverage 
In 2020, CHBRP estimates there will be 24,490,000 total enrollees with health insurance subject to AB 
598; of these, 7,258,000 are enrollees aged 0 to 17 years old.  
Current law does not require coverage for hearing aids as part of a basic contract or offered as an 
optional benefit to groups or individuals. Current coverage of hearing aids for children aged 0 to 17 was 
determined by a survey of the seven largest providers of health insurance in California. Responses to this 
survey represent 73% of enrollees in the privately funded market subject to state mandates. This survey 
was conducted in 2016 for AB 2004, which had the same provisions as AB 598. CHBRP considered 
these data to remain applicable to all plans in California in 2019 because there were no notable changes 
in market structure, plan availability, or health benefits from 2016. 
Based on the responses, approximately 49.1% of enrollees aged 0 to 17 years in California with health 
insurance have coverage that is compliant with AB 598. This estimate includes children in both privately 
funded and publicly funded (e.g., CalPERS HMO, Medi-Cal Managed Care) health insurance products 
regulated by DMHC or CDI. Coverage of hearing aids for privately funded and publicly funded health 
insurance products varies widely: 
• Per CHBRP’s carrier survey, approximately 11% of enrollees aged 0 to 17 years in privately 
funded products have coverage for hearing aids and services. 
• 100% of CalPERS enrollees and Medi-Cal beneficiaries aged 0 to 17 years have hearing aids 
coverage for hearing aids and services. 
Although children covered by Medi-Cal are included in the mandate, these enrollees currently receive 
coverage for hearing aids through the California Children’s Services (CCS) program.42 An unknown 
number of enrollees who are privately insured, but who meet certain financial qualifications, can also 
receive coverage for hearing aids through CCS or charitable organizations (see the Policy Context 
section for more information). 
                                                     
42 Necessary hearing services provided through California Children’s Services to child enrollees in Medi-Cal are billed 
to Medi-Cal, based on personal communication with M. Winter, March 30, 2017. 
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Postmandate Benefit Coverage 
Postmandate, 100% of enrollees aged 0 to 17 years with health insurance would have mandate-
compliant coverage of hearing aids and services; premandate this figure was 49.1%, reflecting an 104% 
change postmandate (see Table 1). 
Baseline and Postmandate Utilization 
Premandate (Baseline) Utilization 
Using the 2016 MarketScan and CHSD databases, CHBRP estimated premandate utilization. CHBRP 
applied the utilization rates estimated from data to all enrollees that currently have coverage and thus 
assumed enrollees in public and private insurance have the same utilization rates. 
There are 16,327 users aged 0 to 17 of hearing aids and/or services currently, including about 8,205 who 
have coverage for these services and 8,123 who do not have coverage. Given that some use more than 
one type of service, there are approximately 11,742 enrollees using hearing aids and/or services including 
replacements, 2,973 enrollees using hearing aid maintenance and repair, 10,129 enrollees who receive 
follow-up ear molds, and 14,009 enrollees using diagnostic tests, hearing aid checks, fittings and 
adjustments (screening that is not initial assessment) during this 1-year period. 
Postmandate Utilization 
CHBRP found enrollees aged 0 to 17 years outside of Medi-Cal and CalPERS largely currently lack 
coverage for hearing aids (approximately 11% of enrollees in privately funded insurance, per CHBRP’s 
carrier survey, have coverage premandate versus 100% for Medi-Cal and CalPERS). Where coverage is 
not offered by the health plan (either as part of a basic plan or as an optional rider), the enrollee is 
responsible for the cost of hearing aids and thus pays for the hearing aid devices and related services out-
of-pocket. Studies suggest hearing aids are largely price inelastic (Amlani, 2010; Amlani and De Silva, 
2005), and the use of pediatric services are largely unaffected by price. Goldman and Grossman (1978) 
find the price elasticity of demand for pediatric visits is between −0.03 and −0.06 (i.e., inelastic). Similarly, 
Wolfson et al. (1982) found no relationship between user fees/cost sharing and the use of services for 
disabled children, suggesting the presence of a disability makes it less likely to reduce the use of medical 
services, and parents are likely less inclined to risk their child’s health by foregoing medical services. Yet, 
it is still quite possible that the introduction of coverage for a previously uncovered service would result in 
an increase in demand (Eichner, 1998). The removal of cost as a barrier when coverage is introduced for 
hearing aids would thus result in utilization uptake. Applying a price elasticity of −0.03 to an assumed 80% 
reduction in cost to the enrollee when coverage is offered to those who did not have coverage before, 
CHBRP estimates an increase in utilization of 2.4% (–0.03 × 80%) among enrollees who did not have 
coverage for hearing aids and services premandate and have coverage postmandate (see Appendix C for 
more detail). 
Translated into utilization change in the first 12 months of enactment of the mandate for all enrollees aged 
0 to 17 subject to AB 598 using hearing aids, CHBRP estimates that postmandate, there would be an 
increase of 1.2% in utilization overall. This reflects the utilization increase that occurs for enrollees who 
were not covered premandate and would have coverage postmandate. Noncovered enrollees premandate 
shift into covered enrollees postmandate (see Table 1). Postmandate, it is estimated that this shift would 
result in increases of 195 newly covered enrollees that will receive a hearing aid or a service due to the 
mandate. Some of these enrollees will receive more than one type of service. Postmandate, CHBRP 
estimates 140 newly covered enrollees will use hearing aid and/or services including replacements, 35 
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newly covered enrollees will use hearing aid maintenance and repair, 121 newly covered enrollees will 
receive ear molds, 167 newly covered enrollees will use diagnostic tests, hearing aid checks, fittings, and 
adjustments (screening that is not initial assessment) over a 1-year period (for further detail, please see 
Appendix C ). 
Impact on access and health treatment/service availability 
AB 598 would increase coverage for hearing aids to those who currently do not have coverage for 
hearing aids and services, but estimates that utilization would increase only moderately. Per CHBRP’s 
content expert and the literature, it appears families generally will acquire hearing aids for their children 
despite the costs, per the price elasticity of demand studies on hearing aids and services for children, 
even if there exists a financial burden on them (Amlani, 2010; Amlani and De Silva, 2005; Eichner, 1998; 
Goldman and Grossman, 1978; Wolfson et al., 1982). CHBRP estimates the current supply of hearing 
aids would be able to meet the demand. CHBRP estimates there would be no change postmandate in the 
service availability of obtaining hearing aids and thus there would be no shortage of these products 
caused by AB 598. 
Baseline and Postmandate Per-Unit Cost  
Based on MarketScan and CHSD Databases, CHBRP estimates hearing aids and/or services cost on 
average $1,825 per user per year (2020 cost). Because this cost is the average annual cost per user, 
where children might use two hearing aids, the average cost per enrollee reflects the cost of both units. 
Also, this average cost per user of hearing aids and/or services includes all types of users, including 
those who receive hearing aids and those may only receive hearing services (e.g., diagnostic tests), but 
do not receive hearing aids, in the 2016 MarketScan and CHSD Databases. Postmandate, CHBRP 
estimates there would be no change in the average per enrollee cost of hearing aids and services. 
Baseline and Postmandate Expenditures 
Table 2 and Table 3 present baseline and postmandate expenditures by market segment for DMHC-
regulated plans and CDI-regulated policies. The tables present per member per month (PMPM) 
premiums, enrollee expenses for both covered and noncovered benefits, and total expenditures 
(premiums as well as enrollee expenses). 
AB 598 would increase total net annual expenditures by $2,685,000 or 0.0017% for enrollees with 
DMHC-regulated plans and CDI-regulated policies. This is due to a $13,809,000 increase in total health 
insurance premiums paid by employers and enrollees for newly covered benefits, adjusted by 
$13,586,000 decrease in enrollee expenses for covered and/or noncovered benefits. 
Premiums 
Changes in premiums as a result of AB 598 would vary by market segment. Note that such changes are 
related to the number of enrollees (see Table 1, Table 2, and Table 3), with health insurance that would 
be subject to AB 598 
Overall, across plan types, CHBRP estimates a 0.0096% increase in premium expenditures, which 
translates into an increase of 0.0017% in total expenditures. For commercial plans regulated by DMHC, 
large-group premiums are estimated to increase by 0.0112%, for small group by 0.0164%, and for 
individual by 0.0126%. Among publicly funded DMHC-regulated health plans, total expenditures for 
CalPERS HMOs, Medi-Cal Managed Care (under 65 years), and Medi-Cal Managed Care (over 65 years) 
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do not change postmandate. For commercial plans regulated by CDI, large-group premiums are estimated 
to increase by 0.0102%, for small group by 0.0136%, and for individual by 0.0131%. 
Enrollee Expenses 
AB 598-related changes in enrollee expenses for covered benefits (deductibles, copays, etc.) and 
enrollee expenses for noncovered benefits would vary by market segment. Note that such changes are 
related to the number of enrollees (see Table 1, Table 2, and Table 3) with health insurance that would be 
subject to AB 598 expected to use the relevant services during the year after enactment. 
CHBRP projects no change to copayments or coinsurance rates but does project an increase in utilization 
of hearing aids and services and therefore an increase in enrollee cost sharing.  
Overall, across plan types, CHBRP estimates an increase of 0.0017% in total expenditures. For 
commercial plans regulated by DMHC, expenditures for large group increase by 0.0019%, for small group 
by 0.0030%, and for individual by 0.0022%. Among publicly funded DMHC-regulated health plans, total 
expenditures for CalPERS HMOs, Medi-Cal Managed Care (under 65 years), and Medi-Cal Managed 
Care (over 65 years) does not change postmandate. For commercial plans regulated by CDI, large-group  
expenditures increase by 0.0015%, for small group by 0.0024%, and for individual by 0.0022%. 
Out-of-Pocket Spending for Covered and Noncovered Expenses 
When possible, CHBRP estimates the marginal impact of the bill on out-of-pocket spending for covered 
and noncovered expenses, defined as uncovered medical expenses paid by the enrollee as well as out-
of-pocket expenses (e.g., deductibles, copayments, and coinsurance). CHBRP estimates that the 
additional 8,123 enrollees with uncovered expenses at baseline would receive a $13,586,000 reduction in 
their out-of-pocket spending for covered and noncovered expenses associated with hearing aids and 
related services (Table 1). Due to new coverage, CHBRP also estimates that total out-of-pocket 
expenses for enrollees with existing coverage baseline and those newly covered who use the hearing 
aids and related services would increase by $2,462,000 under the new mandate. CHBRP estimates are 
based on claims data and may underestimate the cost savings for enrollees due to carriers’ ability to 
negotiate discounted rates that are unavailable to patients and their families. 
Potential Cost Offsets or Savings in the First 12 Months After Enactment 
CHBRP does not project any cost offsets or savings in health care that would result because of the 
enactment of provisions in AB 598.  
Postmandate Administrative Expenses and Other Expenses 
CHBRP estimates that the increase in administrative costs of DMHC-regulated plans and/or CDI-
regulated policies will remain proportional to the increase in premiums. CHBRP assumes that if health 
care costs increase as a result of increased utilization or changes in unit costs, there is a corresponding 
proportional increase in administrative costs. CHBRP assumes that the administrative cost portion of 
premiums is unchanged. All health plans and insurers include a component for administration and profit in 
their premiums. 
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Other Considerations for Policymakers 
In addition to the impacts a bill may have on benefit coverage, utilization, and cost, related considerations 
for policymakers are discussed below. 
Potential Cost of Exceeding Essential Health Benefits 
As explained in the Policy Context section, pediatric hearing aids are not included in California’s EHB 
package. The state is required to defray the additional cost incurred by enrollees in qualified health plans 
(QHPs) for any state benefit mandate that exceeds the state’s definition of essential health benefits 
(EHBs). Coverage for pediatric hearing aids, as would be required if AB 598 were enacted, could trigger 
this requirement and so require the state would to defray related costs. 
CHBRP has considered means of projecting the potential cost to the state of enacting a benefit mandate 
that would exceed EHBs. As federal regulations are not yet final, CHBRP presents in Table 7 several 
scenarios regarding the cost to the state, should AB 598 be judged to exceed EHBs. Impacts would vary 
by market segment (and by market segment enrollment), but would likely range between $0.05 PMPM 
and $0.12 PMPM in a particular market.  
Postmandate Changes in the Number of Uninsured Persons43 
Because the change in average premiums does not exceed 1% for any market segment (see Table 1, 
Table 2, and Table 3), CHBRP would expect no measurable change in the number of uninsured persons 
due to the enactment of AB 598. 
Changes in Public Program Enrollment 
CHBRP estimates that the mandate would produce no measurable impact on enrollment in publicly 
funded insurance programs due to the enactment of AB 598. 
How Lack of Benefit Coverage Results in Cost Shifts to Other Payers 
Because enrollees in public programs already have hearing aid coverage, there is no expected cost 
shifting to occur from the public programs into the privately insured market nor would these public 
programs incur a cost as a result of the mandated offering. However, there may be cost shifting from the 
public programs to the private insurers where privately insured enrollees who qualify and use CCS for 
hearing aids who would no longer use CCS postmandate and thus reduce CCS expenditures. Due to the 
lack of data on the group of privately insured children who use CCS, CHBRP is unable to assess this 
quantitatively. 
                                                     
43 See also CHBRP’s Uninsured: Criteria and Methods for Estimating the Impact of Mandates on the Number of 
Individuals Who Become Uninsured in Response to Premium Increases (December 2015), available at 
http://chbrp.com/analysis_methodology/cost_impact_analysis.php.  
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Table 4. Impacts of AB 598 Impacts on Benefit Coverage, Utilization, and Cost, 2020 
  Baseline Postmandate Increase/ 
Decrease 
Percentage 
Change 
Benefit coverage 
 Total enrollees with health insurance 
subject to state-level benefit mandates 
(a) 
24,490,000 24,490,000 0 0% 
 Total enrollees aged 0–17 years with 
health insurance subject to AB 598 
7,258,000 7,258,000 0 0% 
 Percentage of enrollees aged 0–17 years 
with coverage for hearing aids and 
services (i.e., health insurance compliant 
with AB 598) 
49.1% 100.0% 50.9% 104% 
 Number of enrollees aged 0–17 years 
with coverage for hearing aids and 
services (i.e., health insurance compliant 
with AB 598)  
3,561,000 7,258,000 3,697,000 104% 
Utilization and unit cost 
 Total enrollees aged 0–17 years subject 
to AB598 using hearing aids and/or 
related services 
16,327  16,522  195 1.2% 
Hearing aid and services for enrollees aged 0–17 with hearing aid coverage (number of services) 
 Hearing aids 5,900  11,882  5,981 101% 
 Hearing aid maintenance & 
repair 
1,494  3,009  1,515 101% 
 Ear mold 5,090  10,250  5,160 101% 
 Diagnostic test, hearing aid 
checks, fittings and 
adjustments (c) 
7,040  14,176  7,137 101% 
Hearing aid and services for enrollees aged 0–17 with no hearing aid coverage (number of services) 
 Hearing aids 5,841  0 -5,841 -100% 
 Hearing aid maintenance & 
repair 
1,479  0 -1,479 -100% 
 Ear mold 5,039  0 -5,039 -100% 
 Diagnostic test, hearing aid 
checks, fittings and 
adjustments (c) 
6,969  0 -6,969 -100% 
 Hearing aid and/or services average 
cost per user (d) 
$1,825 $1,825 $0 0% 
Expenditures 
Premiums by payer 
 Private employers for 
group insurance 
$86,438,375,000 $86,448,713,000 $10,338,000 0.0120% 
 CalPERS HMO employer 
expenditures (c) 
$3,098,551,000 $3,098,551,000 $0 0.0000% 
 Medi-Cal Managed Care 
Plan expenditures 
$28,492,273,000 $28,492,273,000 $0 0.0000% 
 Enrollees with individually 
purchased insurance 
$12,045,324,000 $12,046,841,000 $1,517,000 0.0126% 
 Enrollees with group 
insurance, CalPERS 
HMOs, Covered California, 
and Medi-Cal Managed 
Care (c) 
$2,486,222,000 $2,486,591,000 $369,000 0.0148% 
Enrollee expenses 
 For covered benefits 
(deductibles, copayments, 
etc.) 
$14,750,880,000 $14,753,342,000 $2,462,000 0.0167% 
 For noncovered benefits 
(d) 
$13,586,000 $0 -$13,586,000 -100.00% 
Total expenditures $159,315,383,000 $159,318,067,000 $2,684,000 0.0017% 
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Source: California Health Benefits Review Program, 2019. 
Notes: (a) Enrollees in plans and policies regulated by DMHC or CDI aged 0 to 64 years as well as enrollees 65 years or older in 
employer-sponsored health insurance. This group includes commercial enrollees (including those associated with Covered 
California or CalPERS) and Medi-Cal beneficiaries enrolled in DMHC-regulated plans.44  
(c) Enrollee premium expenditures include contributions by employees to employer-sponsored health insurance, health insurance 
purchased through Covered California, and contributions to Medi-Cal Managed Care. 
(d) Includes only expenses paid directly by enrollees (or other sources) to providers for services related to the mandated benefit that 
are not currently covered by insurance. This only includes those expenses that will be newly covered postmandate. Other 
components of expenditures in this table include all health care services covered by insurance. 
Key: CalPERS = California Public Employees’ Retirement System; CDI = California Department of Insurance; DMHC = Department 
of Managed Health Care; HMO = Health Maintenance Organizations. 
 
 
                                                     
44 For more detail, see Estimates of Sources of Health Insurance in California, available at  
http://chbrp.com/analysis_methodology/cost_impact_analysis.php.   
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Table 5. Baseline Per Member Per Month Premiums and Total Expenditures by Market Segment, California, 2020 
  DMHC-Regulated  CDI-Regulated    
  Privately Funded Plans 
(by Market) (a) 
 Publicly Funded Plans  Privately Funded Plans 
(by Market) (a) 
   
  Large 
Group 
Small 
Group 
Individual  CalPERS 
HMOs (b) 
MCMC 
(Under 65) 
(c) 
MCMC 
(65+) (c) 
 Large 
Group 
Small 
Group 
Individual   Total 
Enrollee counts               
 
Total enrollees in 
plans/policies 
subject to state 
mandates (d) 
10,565,000 3,099,000 2,184,000  523,000 6,796,000 795,000  318,000 108,000 102,000   24,490,000 
 
Total enrollees in 
plans/policies 
subject to AB 598 
10,565,000 3,099,000 2,184,000  523,000 6,796,000 795,000  318,000 108,000 102,000   24,490,000 
Premiums               
 
Average portion of 
premium paid by 
employer 
$555.35 $341.99 $0.00  $493.71 $268.13 $694.55  $710.92 $462.84 $0.00 
  
$118,029,198,000 
 
Average portion of 
premium paid by 
employee 
$39.66 $205.44 $437.39  $94.04 $0.00 $0.00  $250.37 $202.64 $475.67 
  
$26,521,718,000 
 Total premium $595.01 $547.43 $437.39  $587.76 $268.13 $694.55  $961.29 $665.48 $475.67   $144,550,916,000 
Enrollee expenses               
 
For covered benefits 
(deductibles, 
copays, etc.) 
$46.18 $121.03 $115.38  $48.33 $0.00 $0.00  $162.44 $186.84 $168.51 
  
$14,750,880,000 
 
For noncovered 
benefits (e) 
$0.07 $0.08 $0.05  $0.00 $0.00 $0.00  $0.10 $0.08 $0.06 
  
$13,586,000 
 Total expenditures $641.26 $668.55 $552.82  $636.08 $268.13 $694.55  $1,123.82 $852.40 $644.23   $159,315,382,000 
Source: California Health Benefits Review Program, 2019. 
Notes: (a) Includes enrollees with grandfathered and nongrandfathered health insurance acquired outside or through Covered California (the state’s health insurance marketplace). 
(b) Approximately 56.17% of CalPERS enrollees in DMHC-regulated plans are state retirees, state employees, or their dependents.  
(c) Medi-Cal Managed Care Plan expenditures for members over 65 include those who are also Medicare beneficiaries. This population does not include enrollees in COHS. 
(d) Enrollees in plans and policies regulated by DMHC or CDI aged 0 to 64 years as well as enrollees 65 years or older in employer-sponsored health insurance. This group includes 
commercial enrollees (including those associated with Covered California or CalPERS) and Medi-Cal beneficiaries enrolled in DMHC-regulated plans.45  
                                                     
45 For more detail, see Estimates of Sources of Health Insurance in California, available at  http://chbrp.com/analysis_methodology/cost_impact_analysis.php.   
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(e) Includes only those expenses that are paid directly by enrollees or other sources to providers for services related to the mandated benefit that are not currently covered by 
insurance. This only includes those expenses that will be newly covered, postmandate. Other components of expenditures in this table include all health care services covered by 
insurance. 
Key: CalPERS HMOs = California Public Employees’ Retirement System Health Maintenance Organizations; CDI = California Department of Insurance; COHS = County Organized 
Health Systems; DMHC = Department of Managed Health Care; MCMC = Medi-Cal Managed Care. 
 
Analysis of California Assembly Bill 598 
Current as of April 4, 2019 www.chbrp.org 31 
Table 6. Postmandate Per Member Per Month Premiums and Total Expenditures by Market Segment, California, 2020 
  DMHC-Regulated  CDI-Regulated   
  Privately Funded Plans 
(by Market) (a) 
 Publicly Funded Plans  Privately Funded Plans 
(by Market) (a) 
  
  Large 
Group 
Small 
Group 
Individual  CalPERS 
HMOs (b) 
MCMC 
(Under  
65) (c) 
MCMC 
(65+) (c) 
 Large 
Group 
Small 
Group 
Individual  Total 
Enrollee counts              
 
Total enrollees in 
plans/policies subject 
to state mandates (d) 
10,565,000 3,099,000 2,184,000  523,000 6,796,000 795,000  318,000 108,000 102,000  24,490,000 
 
Total enrollees in 
plans/policies subject 
to AB 598 
10,565,000 3,099,000 2,184,000  523,000 6,796,000 795,000  318,000 108,000 102,000  24,490,000 
Premiums              
 
Average portion of 
premium paid by 
employer 
$0.0622 $0.0563 $0.0000  $0.0000 $0.0000 $0.0000  $0.0725 $0.0628 $0.0000  $10,339,000 
 
Average portion of 
premium paid by 
employee 
$0.0044 $0.0338 $0.0550  $0.0000 $0.0000 $0.0000  $0.0255 $0.0275 $0.0625  $3,470,000 
 Total premium $0.0667 $0.0901 $0.0550  $0.0000 $0.0000 $0.0000  $0.0981 $0.0903 $0.0625  $13,809,000 
Enrollee expenses              
 
For covered benefits 
(deductibles, copays, 
etc.) 
$0.0137 $0.0121 $0.0074  $0.0000 $0.0000 $0.0000  $0.0141 $0.0121 $0.0084  $2,462,000 
 
For noncovered 
benefits (e) 
-$0.0685 -$0.0821 -$0.0501  $0.0000 $0.0000 $0.0000  -$0.0951 -$0.0824 -$0.0570  -$13,586,000 
 Total expenditures $0.0119 $0.0200 $0.0122  $0.0000 $0.0000 $0.0000  $0.0170 $0.0200 $0.0139  $2,685,000 
Percent change              
 Premiums 0.0112% 0.0164% 0.0126%  0.0000% 0.0000% 0.0000%  0.0102% 0.0136% 0.0131%  0.0096% 
 Total expenditures 0.0019% 0.0030% 0.0022%  0.0000% 0.0000% 0.0000%  0.0015% 0.0024% 0.0022%  0.0017% 
Source: California Health Benefits Review Program, 2019. 
Notes: (a) Includes enrollees with grandfathered and nongrandfathered health insurance acquired outside or through Covered California (the state’s health insurance marketplace). 
(b) Approximately 56.17% of CalPERS enrollees in DMHC-regulated plans are state retirees, state employees, or their dependents  
(c) Medi-Cal Managed Care Plan expenditures for members over 65 include those who are also Medicare beneficiaries. This population does not include enrollees in COHS. 
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(d) Enrollees in plans and policies regulated by DMHC or CDI aged 0 to 64 years as well as enrollees 65 years or older in employer-sponsored health insurance. This group includes 
commercial enrollees (including those associated with Covered California or CalPERS) and Medi-Cal beneficiaries enrolled in DMHC-regulated plans.46  
(e) Includes only those expenses that are paid directly by enrollees or other sources to providers for services related to the mandated benefit that are not currently covered by 
insurance. This only includes those expenses that will be newly covered, postmandate. Other components of expenditures in this table include all health care services covered by 
insurance. 
Key: CalPERS HMOs = California Public Employees’ Retirement System Health Maintenance Organizations; CDI = California Department of Insurance; COHS = County Organized 
Health Systems; DMHC = Department of Managed Health Care; MCMC = Medi-Cal Managed Care. 
 
 
                                                     
46 For more detail, see Estimates of Sources of Health Insurance in California, available at  http://chbrp.com/analysis_methodology/cost_impact_analysis.php.   
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Table 7. Estimated State Responsibility for Portion of Mandate  
    DMHC-Regulated   CDI-Regulated   
    
Small 
Group Individual   
Small 
Group Individual Total 
Enrollee counts             
  
Total enrollees in plans/policies subject 
to state mandates 
3,099,000 2,184,000 
 
108,000 102,000 5,493,000 
  Number of enrollees in QHPs (a) 658,000 2,077,000 
 
12,000 65,000 2,812,000 
Premium cost of mandated benefit   
     
  
Estimated premium cost of mandated 
benefit (b) 
$0.12 $0.08 
 
$0.07 $0.08 $0.09 
  
Marginal premium impact with offsets 
(c) 
$0.12 $0.08 
 
$0.07 $0.08 $0.09 
  
Marginal premium impact considering 
baseline coverage (d) 
$0.09 $0.05 
 
$0.09 $0.05 $0.06 
Estimated annual state responsibility for 
portion of mandate that is in excess of 
EHB 
  
     
  
Scenario 1—Full estimated cost (e) = 
(a) × (b) × 12 
$915,000 $2,080,000 
 
$9,000 $62,000 $3,067,000 
  
Scenario 2—With cost offsets (f) = (a) × 
(c) × 12 
$915,000 $2,080,000 
 
$9,000 $62,000 $3,067,000 
  
Scenario 3—With baseline coverage 
offset (g) = (a) × (d) × 12 
$711,000 $1,337,000 
 
$14,000 $41,000 $2,102,000 
 
Source: California Health Benefits Review Program, 2019.  
Notes: (a) States are required to defray the costs of state-mandated benefits that are in excess of the EHB for QHPs. QHPs are a 
subset of the plans offered in the individual and small group markets. 
(b) Estimated full cost of the mandated benefit without offsets for reduction in costs for related benefits that are EHBs.  
(c) Estimated marginal premium impact considering some of the increase in costs associated with a given benefit mandate may be 
offset by reductions in costs for related benefits that are EHBs. 
(d) Estimated marginal premium impact of the proposed mandated benefit considering some QHPs may already cover the 
mandated benefit. It is yet to be determined whether the State is responsible for defraying the full cost of the mandated benefit in 
this circumstance. 
Key: CDI = California Department of Insurance; DMHC = Department of Managed Health Care; EHB = essential health benefit; QHP 
= qualified health plan. 
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PUBLIC HEALTH IMPACTS 
As discussed in the Policy Context section, AB 598 would require DMHC-regulated health plans and CDI-
regulated policies to provide coverage of hearing aids for children aged 0–17 years, as well as publicly 
funded plans that are subject to the Knox-Keene Health Care Services Plan Act.  
The public health impact analysis includes estimated impacts in the short term (within 12 months of 
implementation) and in the long term (beyond the first 12 months postmandate). This section estimates 
the short-term impact47 of AB 598 on mandate-relevant health outcomes, potential side effects, impact on 
disparities, financial burden, and economic loss. See the Long-Term Impacts section for discussion of 
economic loss, educational attainment, and employment opportunities. 
Estimated Public Health Outcomes 
Early diagnosis and treatment for hearing loss in children is an important step to producing better speech 
and language outcomes (Yoshinaga-Itano and Apuzzo, 1998). Close to 100% of newborns in California 
are screened at birth for hearing loss through the Newborn Hearing Screening Program; for those infants 
diagnosed with hearing loss, early treatment with hearing aids and/or therapy are available. For children 
who acquire hearing loss later in childhood, hearing screening tests are conducted through clinicians’ 
offices or through the public education system; referrals are made to audiologists for those requiring 
diagnostic testing.  
Once a child is determined to have hearing loss, delays in obtaining hearing aids can occur. In a survey 
of 352 U.S. parents with young children diagnosed with hearing loss, Muñoz et al. (2013) found three 
primary challenges to parents in obtaining timely hearing aid fittings for their children. The top three 
reasons included problems paying for hearing aids (30%), problems paying for ear molds (17%), and 
problems accepting the need for hearing aids (21%). Thirty-five percent reported no problems at all. Sixty-
four percent of those surveyed reported incomes of greater than $60,000, and 37% reported purchasing 
hearing aids through private insurance (Muñoz et al., 2013). 
As presented in the Medical Effectiveness section, there is a preponderance of evidence that early 
diagnosis and treatment of hearing loss with hearing aids significantly improves the intelligibility of 
children’s speech, and language development. Evidence also showed that gains in nonverbal 
understanding and interactions and improvements in personal/social development in children with hearing 
aids did not reach statistical significance. It is noted that, for many hard of hearing children, there is a 
synergistic relationship between hearing aids and adjuvant speech and language therapy or other 
educational interventions; each component is necessary to achieve the improved outcomes sought by the 
patients and their families (CHBRP, 2007). 
As presented in the Benefit Coverage, Utilization, and Cost Impacts section, an additional 195 children 
needing hearing aids or services would be newly covered under AB 598 postmandate. For some, this 
permits first-time use of hearing aids, and for all newly covered hearing aid users, it permits more repairs, 
replacements, testing, and recasted ear molds, which improve the effectiveness of the hearing aids. All of 
these newly covered children would be in privately funded health insurance plans or policies because 
Medi-Cal and CalPERS currently cover hearing aids and services.  
                                                     
47 CHBRP defines short-term impacts as changes occurring within 12 months of bill implementation. 
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In the first year postmandate, CHBRP estimates that a total of 195 children will become first-time users 
(all in the privately funded insurance market). There is a preponderance of evidence that early diagnosis 
and treatment of hearing loss with hearing aids and services is medically effective. Thus, assuming new 
coverage terms are similar to premandate cost-sharing terms, hearing and speech and language skills 
would be expected to improve for this subset of newly covered children with hearing loss who were 
unable to afford hearing aids or timely repairs/replacements premandate. (See the Estimated Impact on 
Financial Burden section for further discussion.) 
Potential Difficulties From AB 598 
When data are available, CHBRP estimates the marginal change in relevant harms associated with 
interventions affected by the proposed mandate. In the case of AB 598, hearing aids do not produce 
harms, but there are several common problems associated with the use of hearing aids. These include 
discomfort from the user’s voice sounding too loud (occlusion effect), feedback from the hearing aid, 
background noise, a buzzing sound with cellphone use, and feeling physically uncomfortable. Many of 
these problems can be attenuated through adjustments performed by an audiologist. Additionally, 
perceived social stigma associated with hearing aids may inhibit consistent use by children (Kent and 
Smith, 2006). Despite these issues with hearing aids, there is a preponderance of evidence that early 
diagnosis and treatment of hearing loss with hearing aids significantly improves the intelligibility of 
children’s speech, and language development which clearly outweigh these identified problems. 
Impact on Disparities48 
Insurance benefit mandates that bring all state-regulated plans and policies to parity may change an 
existing disparity.35 As described in the Background on Hearing Aids: Minors section, disparities in 
pediatric hearing loss exist by gender and race/ethnicity in addition to disparities in obtaining screening 
and hearing aids for hearing loss. Within the first 12 months postmandate, CHBRP estimates AB 598 
could reduce disparities in gender and race/ethnicity. (For a discussion of potential impacts beyond the 
first 12 months of implementation, see the Long-Term Impacts section.) As noted in the Background on 
Hearing Aids: Minors section, coverage of hearing aids through the Medi-Cal program in California may 
reduce disparities by eliminating financial barriers for low-income children, but Medi-Cal coverage would 
not address other barriers such as lack of education or geographic location listed above. The extent to 
which AB 598 would address these disparities is unknown. 
 
No literature has been found, through 2019, that discussed the receipt of hearing aids and its effect on 
ameliorating existing disparities in hearing loss by gender, income, and maternal education in addition to 
disparities in obtaining screening and hearing aids for hearing loss (as described in the Background on 
Hearing Aids: Minors section).  
                                                     
48For details about CHBRP’s methodological approach to analyzing disparities, see the Benefit Mandate Structure 
and Unequal Racial/Ethnic Health Impacts document here: 
http://chbrp.com/analysis_methodology/public_health_impact_analysis.php. 
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Impact on Racial or Ethnic Disparities 
Insurance benefit mandates that bring all state-regulated plans and policies to parity may change an 
existing disparity.35 As described in the Background on Hearing Aids: Minors section, disparities in 
pediatric hearing loss exist by gender and race/ethnicity in addition to disparities in obtaining screening 
and hearing aids for hearing loss. Within the first 12 months postmandate, CHBRP estimates AB 598 
could reduce disparities in gender and race/ethnicity. (For a discussion of potential impacts beyond the 
first 12 months of implementation, see the Long-Term Impacts section.) As noted in the Background on 
Hearing Aids: Minors section, coverage of hearing aids through the Medi-Cal program in California may 
reduce disparities by eliminating financial barriers for low-income children, but Medi-Cal coverage would 
not address other barriers such as lack of education or geographic location listed above. The extent to 
which AB 598 would address these disparities is unknown. 
 
No literature was found that discussed the receipt of hearing aids and its effect on ameliorating existing 
disparities in hearing loss by gender, income, and maternal education in addition to disparities in 
obtaining screening and hearing aids for hearing loss (as described in the Background on Hearing Aids: 
Minors section).  
Estimated Impact on Financial Burden 
When possible, CHBRP estimates the marginal impact of mandates on financial burden, defined as 
uncovered medical expenses paid by the enrollee as well as out-of-pocket expenses (e.g., deductibles, 
copayments, and coinsurance). AB 598 would decrease the financial burden for families of those 
enrollees who are newly covered and use hearing aids in several ways. CHBRP estimates that the 
additional 5,841 newly covered children using hearing aids, the families of 195 children would be able to 
purchase otherwise unaffordable hearing aids due to new coverage. CHBRP estimates that the annual 
out-of-pocket costs for families of the newly 5,841 children would decrease by $13.59 million 
postmandate, which would be offset by an increase in $2.46 million in cost sharing, for an overall $11.13 
million reduction in out-of-pocket expenses associated with the use of hearing aids and services. CHBRP 
estimates are based on claims data and may underestimate the cost savings for enrollees due to carriers’ 
ability to negotiate discounted rates that are unavailable to patients and their families. A study by 
Gallaudet Research Institute found that, of hard of hearing students in California, 17% have a sibling who 
is also hard of hearing or deaf (Gallaudet Research Institute, 2011). For those families with more than 
one child who uses hearing aid(s), AB 598 would bring them additional savings. (These estimates hold 
true postmandate, assuming that new coverage meets or exceeds current levels of coverage, usually 
around $1,000 cap every 3 to 5 years; AB 598 does not require a specific level of cost-sharing.)  
CHBRP estimates that AB 598 would modify coverage and reduce the net financial burden by 
approximately $13.59 million in the first year postmandate for the families of 5,841 children using hearing 
aids and services. 
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LONG-TERM IMPACTS 
In this section, CHBRP estimates the long-term impact49 of AB 598, which CHBRP defines as impacts 
occurring beyond the first 12 months after implementation. These estimates are qualitative and based on 
the existing evidence available in the literature. CHBRP does not provide quantitative estimates of long-
term impacts because of unknown improvements in clinical care, changes in prices, implementation of 
other complementary or conflicting policies, and other unexpected factors. 
Long-Term Utilization and Cost Impacts 
Regarding utilization impacts, CHBRP estimates AB 598 would have minimal impacts on utilization. 
Premium expenditures by payer increase with AB 598. However, as technology changes, it is possible 
that unit costs of these devices will change. In the absence of data on likely changes to unit cost of 
hearing aids, the long-term impact is not quantifiable. 
Regarding public health impacts, The degree to which the passage of AB 598 would improve the future 
educational attainment and employment status of children who obtain hearing aids through the new 
coverage is unknown. However, it stands to reason that those who use hearing aids at a young age and 
maintain their communication skills into adulthood would experience improved outcomes as compared 
with not using hearing aids. 
 
 
 
                                                     
49 See also CHBRP’s Criteria and Guidelines for the Analysis of Long-Term Impacts on Healthcare Costs and Public 
Health, available at http://www.chbrp.org/analysis_methodology/cost_impact_analysis.php.  
Analysis of California Assembly Bill 598 
Current as of April 4, 2019 www.chbrp.org A-1 
APPENDIX A  TEXT OF BILL ANALYZED 
On February 19, 2019, the California Assembly Committee on Health requested that CHBRP analyze AB 
598. 
ASSEMBLY BILL No. 598 
 
Introduced by Assembly Member Bloom 
(Coauthors: Assembly Members Gallagher and Mullin) 
 
February 14, 2019 
 
An act to add Section 1367.72 to the Health and Safety Code, and to add Section 10123.72 to the 
Insurance Code, relating to healthcare coverage. 
 
LEGISLATIVE COUNSEL'S DIGEST 
 
AB 598, as introduced, Bloom. Hearing aids: minors. 
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure 
and regulation of health care service plans by the Department of Managed Health Care and makes 
a willful violation of the act a crime. Existing law also provides for the regulation of health insurers 
by the Department of Insurance. Existing law requires health care service plan contracts and health 
insurance policies to provide coverage for specified benefits. 
 
This bill would require a health care service plan contract or a health insurance policy issued, 
amended, or renewed on or after January 1, 2020, to include coverage for hearing aids, as defined, 
for an enrollee or insured under 18 years of age, as specified. Because a willful violation of these 
requirements by a health care service plan would be a crime, this bill would impose a state-
mandated local program. 
 
The California Constitution requires the state to reimburse local agencies and school districts for 
certain costs mandated by the state. Statutory provisions establish procedures for making that 
reimbursement. 
 
This bill would provide that no reimbursement is required by this act for a specified reason. 
 
DIGEST KEY 
Vote: majority   Appropriation: no   Fiscal Committee: yes   Local Program: yes   
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BILL TEXT 
 
THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS: 
 
SECTION 1. 
 The Legislature finds and declares as follows: 
 
(a) In the United States, approximately 3.5 percent of adolescents 12 to 19 years of age are deaf or 
hard of hearing. This includes those who were born deaf or hard of hearing as well as those who 
later acquired that hearing status. 
 
(b)  Studies have shown that early diagnosis of a child’s hearing status and quick intervention is 
critical to developing language and improving speech outcomes. Research supported by the 
National Institutes of Health identify the first three years of life as the most intensive period of 
speech and language development in children. 
 
(c)  Studies have shown that the earlier a deaf or hard of hearing child has access to interventions, 
the better the child’s spoken language outcomes are. 
 
(d)  In 2006, California passed Assembly Bill 2651, implementing a comprehensive newborn 
hearing screening program to identify the hearing status of newborns and guide parents to 
appropriate services. The program’s stated goal is to identify hearing status in infants before three 
months of age and subsequently link those events to intervention services by six months of age. 
 
(e) The National Institutes of Health, Centers for Disease Control and Prevention, and American 
Academy of Pediatrics all stress that newborns should have their hearing status identified by age 
one month, diagnosed by three months, and should receive early interventions by six months of 
age. 
 
(f)  California, however, does not require insurance companies to cover hearing aids, making an 
important intervention financially inaccessible or burdensome to many parents. 
 
(g)  Hearing aids provide a significant financial burden to many California families. A 2013 survey 
found cost to be the most significant challenge to obtaining timely hearing aid fittings, with 30 
percent of parents reporting problems paying for hearing aids and 17 percent reporting problems 
with paying for ear molds. 
 
(h)  Hearing aids are expensive, costing on average between $1,500 and $4,000 per ear, and up to 
$6,000 in many cases. Additionally, these devices have to be replaced frequently to accommodate 
a child’s growth. Families also incur additional costs from hearing aid services, including fittings 
and repairs. 
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(i) Fewer than one in 10 Californian children on privately funded plans have coverage for pediatric 
hearing aids and hearing aid services. As a result, thousands of families are forced to pay the steep 
costs for these devices out of pocket or forego hearing aids for their children. 
 
(j) It is the intent of the Legislature to ensure that deaf and hard of hearing children have a 
continuous pathway from screening to diagnosis to intervention. The lack of insurance coverage 
remains a significant obstacle to that pathway and must be addressed. 
 
SEC. 2. Section 1367.72 is added to the Health and Safety Code, to read: 
 
1367.72 (a) (1) A health care service plan contract issued, amended, or renewed on or after January 
1, 2020, shall include coverage for hearing aids for all enrollees under 18 years of age when 
medically necessary. 
 
(2) Coverage for hearing aids includes an initial assessment, new hearing aids at least every five 
years, new ear molds, new hearing aids if alterations to existing hearing aids cannot meet the needs 
of the child, a new hearing aid if the existing one is no longer working, fittings, adjustments, 
auditory training, and maintenance of the hearing aids. 
 
(b) For purposes of this section, “hearing aid” means an electronic device designed to aid or 
compensate for impaired human hearing and any parts, attachments, or accessories, including 
earmolds, but excluding batteries and cords. This includes both hearing aids traditionally worn 
behind the ear and auditory osseointegrated devices, whether implanted or worn externally. 
 
(c) This section shall not apply to Medicare supplement, dental-only, or vision-only health care 
service plan contracts. 
 
SEC. 3. Section 10123.72 is added to the Insurance Code, to read: 
 
10123.72 (a) (1) A health insurance policy issued, amended, or renewed on or after January 1, 
2020, shall include coverage for hearing aids for all insureds under 18 years of age when medically 
necessary. 
 
(2) Coverage for hearing aids includes an initial assessment, new hearing aids at least every five 
years, new ear molds, new hearing aids if alterations to existing hearing aids cannot meet the needs 
of the child, a new hearing aid if the existing one is no longer working, fittings, adjustments, 
auditory training, and maintenance of the hearing aids. 
 
(b) For purposes of this section, “hearing aid” means an electronic device designed to aid or 
compensate for impaired human hearing and any parts, attachments, or accessories, including 
earmolds, but excluding batteries and cords. This includes both hearing aids traditionally worn 
behind the ear and auditory osseointegrated devices, whether implanted or worn externally. 
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(c) This section shall not apply to accident-only, specified disease, hospital indemnity, Medicare 
supplement, dental-only, or vision-only health insurance policies. 
 
SEC. 4. No reimbursement is required by this act pursuant to Section 6 of Article XIII B of the 
California Constitution because the only costs that may be incurred by a local agency or school 
district will be incurred because this act creates a new crime or infraction, eliminates a crime or 
infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 
of the Government Code, or changes the definition of a crime within the meaning of Section 6 of 
Article XIII B of the California Constitution. 
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APPENDIX B  COST IMPACT ANALYSIS: DATA 
SOURCES, CAVEATS, AND ASSUMPTIONS 
This subsection discusses the caveats and assumptions relevant to specifically to an analysis 
of AB 598. 
• The population subject to the mandated offering includes children covered by DMHC-regulated 
commercial insurance plans and CDI-regulated policies and publicly funded plans (including 
CalPERS and Medi-Cal) subject to the requirements of the Knox-Keene Health Care Service Plan 
Act. Health plans and insurers could currently comply with this mandate in one of two ways: (1) as 
a written agreement, or rider, that attaches to a policy to modify insurance coverage; or (2) as part 
of their basic benefit package. CHBRP assumes that carriers would provide coverage to comply 
with AB 598 post-mandate in the base plan to avoid adverse selection (attracting members who 
anticipated using this benefit). CalPERS and Medi-Cal currently offer coverage for hearing aids 
and are thus already compliant with AB 598. 
• AB 598 exceeds Essential Health Benefits (EHBs) because hearing aids for children are not a part 
of California’s EHBs/benchmark plan. 
• Healthcare Common Procedure Coding System (HCPCS) and Current Procedural Terminology 
(CPT) codes related to hearing aids, including codes related to screening and diagnostics, hearing 
aid fittings, ear molds, maintenance and repairs, and replacements, were identified with CHBRP’s 
content expert. Below is the list of HCPCS and CPT codes categorized under each group: 
o Hearing Aid: 69714, 69799, L8690, L8692, V5030, V5050, V5060, V5080, V5090, V5110, 
V5130, V5140, V5160, V5180,V5220, V5241, V5246, V5253, V5254, V5255, V5256, V5257, 
V5258, V5259, V5260, V5261, V5267, V5272, V5274, V5282, V5283, V5287, V5288, V5289, 
V5298, V8692 
o Maintenance and Repair: 69711, L7510, L7520, V5014, V5299 
o Ear Molds: V5264, V5265, V5275 
o Assessment: 92590, 92591, 92592, 92593, 92594, 92595, V5010, V5011 
o Replacement: L8691 
• The following hearing aid codes were excluded as they identify services not covered by AB 598: 
Codes relating to cochlear implants, Codes relating to battery and cord replacements, and Codes 
associated with auditory screening other than hearing-aid assessments and thus covered under 
California’s EHB’s were also excluded from the analysis. 
• As AB 598 applies only to minors, the final claims database used was limited to 0- to 17-year-
olds. CHBRP summarized five categories of hearing aid services within the claims data and thus 
reports utilization by these categories in Table 1: Hearing aids; Hearing aid maintenance and 
repair; Replacement; Ear mold; and Diagnostic assessments, fittings, and adjustments.  
• The identified HCPCS and CPT codes were used to extract data from Milliman’s 2016 
Consolidated Health Cost Guidelines Sources Database (CHSD) and the 2016 MarketScan® 
Commercial Claims and Encounters Database. These data were used to develop baseline cost 
and utilization information for hearing aids. Baseline cost and utilization rates per 1,000 members 
were calculated and used to estimate enrollee counts for each service type and cost per user. 
Cost of hearing aids and services does not include any additional costs from warranties or other 
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add-on costs to protect hearing aids that might be purchased by families obtaining hearing aids 
for children. 
• Baseline cost was trended at a 2.0% annual rate of increase from 2016 to 2020 based on the 
2018 medical consumer price index (CPI) rate, for a total increase in cost of 8.2% over the time 
period. 
• Carrier surveys were administered to estimate the percentage of enrollees who have hearing aid 
coverage pre-mandate along with typical cost-sharing for those who do have coverage. 
o To estimate the total number of services provided, CHBRP estimated the percentage of 
children with coverage for hearing aids in the 2016 claims database, based on responses to 
the carrier surveys for the analysis of a similar bill introduced in 2017, SB 1601. 
o The surveys revealed that 10% of commercially insured enrollees have this coverage. 
o CHBRP then calculated the utilization rate as a percentage of enrollees; the analysis showed 
that 0.26% of children received at least one of the relevant hearing aid services. For each of 
the service types, CHBRP calculated a similar value. CHBRP then applied the utilization 
rates to each of the population cohorts that currently have coverage. All Medi-Cal children, 
who do have coverage for hearing aids and services were assumed to have utilization rates 
at the same levels as commercially insured children. 
• Because there are no data sources that show by how much hearing aid utilization increases when 
coverage for hearing aids is mandated (i.e., there are no longitudinal studies examining changes 
utilization before and after legislation has been implemented in other states), CHBRP used content 
expert input for the analysis of a prior bill, SB 1601, and information in the peer-reviewed literature to 
estimate the most likely utilization change that would occur if AB 598 were to be enacted. The 
following describes the sources of information that were gathered to make an assessment of 
utilization change: 
Cost has been cited as a barrier to the acquisition of hearing aids in a study of 352 U.S. 
parents with young children diagnosed with hearing loss (Muñoz et al., 2013). This study 
found approximately 1% of the study population did not get hearing aids due to cost (4 out of 
352) and is consistent with the price elasticity of demand literature described below that 
points to hearing aids and pediatric services being largely inelastic. 
o Price elasticity of demand —- the measure of the relationship between a change in the 
quantity demanded of a good (in this case, hearing aids for children) and a change in its price 
— is a key input to estimating utilization change when cost to the consumer changes when 
coverage is given. There are estimates of the price elasticity of demand for hearing aids, 
suggesting hearing aids are largely inelastic, which means the demand or use of the good is 
largely unaffected by price change (price elasticity of demand ranges between −0.31 and 
i−0.54 [Amlani, 2010; Amlani and De Silva, 2005]). These price elasticity of demand 
estimates for hearing aids, however, are not specific to pediatric hearing aids. Thus, going to 
the broader body of literature on pediatric services, there is evidence that the price elasticity 
of demand for pediatric clinical visits is also low: Goldman and Grossman (1978) find the 
price elasticity of demand for pediatric visits to be −0.03 to −0.06. Similarly, Wolfson et al. 
(1982) found no relationship between user fees/cost sharing and the use of services among 
disabled children, suggesting the presence of a disability makes it less likely to reduce the 
use of medical services and parents are likely less inclined to risk the child’s health by 
foregoing medical services. Despite the evidence pointing to the price inelasticity of demand 
for child hearing aids, CHBRP recognizes it is still possible that the introduction of coverage 
for a previously uncovered service would result in some increase in demand (Eichner, 1998). 
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The removal of cost as a barrier when coverage is introduced for hearing aids thus is 
assumed to result in utilization uptake. Assuming a family has no coverage for hearing aids, 
the family pays 100% of the cost. If their insurance plan were to cover hearing aids such that 
the enrollee pays 20% out of pocket, the family experiences an 80% reduction in cost. 
Applying a price elasticity of −0.03 (low point estimate from Goldman and Grossman [1978] of 
price elasticity of demand for pediatric visits; the low point is chosen to better reflect the more 
inelastic nature of a medical service for a disability in children per Wolfson and colleagues 
[1982]) to the assumed 80% reduction in cost, there would be a 2.4% (−0.03 × 80%) increase 
in demand/utilization of hearing aids. CHBRP thus assumed pre-mandate baseline utilization 
is lower among noncovered enrollees compared to covered enrollees such that postmandate, 
AB 598 would result in an increase in utilization of 2.4% among noncovered enrollees, 
bringing utilization among noncovered enrollees up to par with utilization among covered 
enrollees. This assumption is consistent with the assumption applied in the cost analysis of 
hearing aids bill AB 368 by CHBRP in 2007 in which CHBRP estimated a baseline 
premandate utilization rate 2% less for those who lack coverage, which was based on a 
survey conducted in 2003 by the Listen Up organization that found approximately 1% of 
respondents cited cost as a barrier to obtaining a hearing aid for their child with hearing loss 
(CHBRP, 2007). 
o CHBRP’s content expert pointed out that there exist a number of ways families might receive 
help for obtaining hearing aids if cost poses a barrier. For currently noncovered enrollees who 
meet certain financial qualifications, they can receive financial aid and full coverage for 
hearing aids. California Children’s Services (CCS) is available for hearing aid services for 
children who are commercially insured but do not have a hearing aid benefit or have high out- 
of-pocket costs for hearing aids depending on their financial status. There are other charitable 
organizations that provide hearing aids for free or at a drastic discount, based on specified 
financial qualifications. For example, the Miracle-Ear Children’s Foundation provides hearing 
aids to children 18 years or younger whose families are low income but do not qualify for 
public support (Miracle-Ear Children’s Foundation, 2016). Utilization rates and cost data for 
enrollees obtaining hearing aids through CCS, charitable organizations, or for those 
purchasing units fully out of pocket, are not available and thus not included in this analysis. 
• Health plans and insurers often provide discounts to members or subscribers. Even if health 
plans and insurers do not cover hearing aids, it is common for many to have relationships with 
vendors to provide a discount to their members or subscribers. These relationships may change 
postmandate; however, due to the uncertainty in how the mandate would shift provider–vendor 
relationships, CHBRP is unable to estimate impacts of these changes. 
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CALIFORNIA HEALTH BENEFITS REVIEW PROGRAM 
COMMITTEES AND STAFF 
A group of faculty, researchers, and staff complete the analysis that informs California Health Benefits 
Review Program (CHBRP) reports. The CHBRP Faculty Task Force comprises rotating senior faculty 
from University of California (UC) campuses. In addition to these representatives, there are other ongoing 
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